Tag: Big Pharma

Health Friday 10.11.2024: About The Bird Flu Summit This Month in Virginia

The above blurred image of persons attending a conference is courtesy of Google Images and Vecteezy.

Today’s Health Friday offering is one a of a series devoted to Big Pharma, vaccines, general health, and associated topics. The discussion is not limited to what is presented in today’s post: it is an Open Thread.

There are Important Wolf Moon Notifications; the Rules of our late, good Wheatie; and other items that readers should be familiar with. They are all linked here.

This post will be diving into some “interesting” rabbit-holes. Stay with Yours Truly — I believe they are all interconnected. There is a General Summary at the end of the post.

The trail, for today’s purposes, begins with the following links: www.theburningplatform.com/2024/10/04/exclusive-new-york-city-health-officials-to-hold-bird-flu-tabletop-exercise/, 4 October 2024, by Michael Nevradakis, Ph.D.; https://childrenshealthdefense.org/defender/nyc-health-officials-bird-flu-summit-tabletop-simulated-plan/, 3 October 2024, by the same author (goes into more detail); and, www.theqtree.com/2024/08/02/the-hhs-gave-the-go-ahead-to-use-an-h5n1vaccine-but-the-ama-just-issued-new-cpt-codes-for-an-h5n8-vaccine/, 8 August 2024, by Yours Truly.

Note: the scientific paper referred to by Dr. Nevradakis is here: www.preprints.org/manuscript/202406.0060/v1, “Proximal Origin of Epidemic Highly Pathogenic Avian Influenza H5N1 Clade 2.3.4.4b and Spread by Migratory Waterfowl”, Nicolas Hulscher, John Leake, Peter McCullough, 3 June 2024; click on “Download PDF” to read or save the paper. The authors suspect Gain-of-Function to be in play. Below is the Abstract of the paper:

Since this paper is a preprint; and, that it may be a target for Retraction; Withdrawal; or, Reissue with “new conclusions” that would reflect pressure on the paper’s authors and/or the publisher, Yours Truly suggests that interested readers download or make a hard copy of the preprint version.

The International Bird Flu Summit was held in Fairfax, Virginia, on 2 – 4 October 2024. This is the website for the “summit”: https://birdflusummit.com/. Here is the Brochure for the “summit”: https://birdflusummit.com/Bird Flu Summit Brochure.pdf. Reading through these “summit” websites, one gets the distinct impression of a general tone that “a Bird Flu pandemic” is about to occur; and, that various “interventions”, “command and control” methods, and “monitoring and dismantling” of “misinformation” detected on social media platforms, etc., will be “necessary” as part of a “coordinated response.”

Taking a look at the Brochure for the “Bird Flu Summit”, here is a portion of one of the “overview” pages:

Seems innocuous enough. However, moving on in the Brochure, one finds this:

And, further along in the Brochure, there is this:

Military involvement? “Inter-agency Communication and Resource Allocation”? What is “Seamless Response”?

John Leake, who works with Dr. Peter McCullough, attended this “summit.” Here is his take: https://petermcculloughmd.substack.com/p/at-the-bird-flu-summit, 2 October 2024. Yours Truly agrees with his impression that the speakers at the “summit” were “middle-of-the-road, rather than barn-burning experts” (my phrase.) One also agrees with the impression that the “summit” was all about “a Bird Flu pandemic being just around the corner.” However, this is NOT to minimize the potential for something like a “bird flu epidemic / pandemic” occurring — either from a “natural cause”: or, by another “lab leak.” Here is another view on the situation: www.theburningplatform.com/2024/09/22/could-bird-flu-be-the-october-surprise/, by Clayton J. Baker, MD.

FLASH! — The McCullough Foundation just got a demand from one of the speakers at the “Bird Flu Summit”, Syra Madad, PhD, to delete a video that John Leake and Nicolas Hulscher (another McCullough Foundation member) made of a Question-and-Answer session between Mr. Leake and herself at the “summit.” Dr. Madad is the coordinator of the upcoming New York City “Bird Flu Response Conference.” Please see here: https://petermcculloughmd.substack.com/p/mccullough-foundation-receives-bird, “McCullough Foundation Receives Bird Flu Summit Censorship Demand”, 9 October 2024. Below is a portion of the article:

The transcript of the video follows in the article (the video was deleted.) Below is a portion of the transcript, followed by an assessment by Mr. Leake:

Turning to the entity that “presented” the event (Ginkgo Biosecurity), and the entity that “produced” the event (SyllabusX): this is where the “rabbit holes” emerge; and, something that Yours Truly will call the Big Pharma-Government-Medical Complex (BPGMCTM) comes into the situation. Yours Truly defines BPGMC as an “interwoven cooperation” among Big Pharma, Federal government agencies regarding development / funding / support (including the Department of Defense), institutional investors, private investors, and “Establishment Medicine” (CDC, FDA, AMA, etc.)

First, the “producer” of the “Bird Flu Summit”, SyllabusX. The company’s address and phone number: 1900 Campus Commons Dr., Suite 100, Reston, VA 20191; phone number: 703.466.0011. The company was founded in 2017. SyllabusX has its “fingers in many pies” regarding producing conferences and other events on student safety and security, on technology for educators, on health and biosecurity, and more (https://syllabusx.com/home-2; and, https://syllabusx.com/about-us.) (Note: it is not easy to find information online about this company, especially as regards financials. A couple of sources that Yours Truly found: https://pitchbook.com/profiles/company/520513-39#overview; and, www.zoominfo.com/c/syllabusx-inc/480230653.) It appears that SyllabusX is a “privately-held company.”

The Chief Research Officer of SyllabusX is Ahmed Al Faraj (www.linkedin.com/in/ahmed-al-faraj; Note: this link may not work, unless the reader first joins LinkedIn.) And here’s where the issue gets, IMO, interesting. It appears that Mr. Faraj graduated with a B.S. in Economics from the University of Kansas School of Business in 2006. His languages are listed as, “Native or bilingual proficiency” in Arabic.

Before starting SyllabusX, Mr. Faraj previously worked for a company called New-Fields Exhibitions, headquartered in Dubai (https://inf.ae/.) While at New-Fields Exhibitions, Mr. Faraj held positions as Program Manager, Education & Public Health Group; and. as Program Manager, Defense Business Group. Below are two screenshots from the type of work he performed while at New-Fields Exhibitions:

Mr. Faraj also previously worked for a company called AdvanFort. He was the Chief Operating Officer of this company. AdvanFort is owned by a person called Samir Farajallah. His son, the then-Chief Operating Officer, was called Ahmed Farahjallah. AdvanFort is “a US private maritime security company”, per Wikipedia. The company was founded in 2007, and its headquarters office is in Herndon, VA (www.advanfort.com/.) A vessel owned by AdvanFort was involved in an international maritime incident in 2014. One of the stories that covers this incident is here: www,bbc.com/news/uk-england-34095843, 7 September 2015, “AdvanFort accused of abandoning British men facing India trial.” As a result of this incident, AdvanFort withdrew from membership in SAMI (the Security Association for the Maritime Industry): https://gcaptain.com/sami-responds-accusations-from-advanfort/, 2 April 2014. (Interested readers may want to compare the photo of Ahmed Faraj on the SyllabusX LinkedIn site, to the photo of Samir Farajallah and Ahmed Farajallah that is in the BBC article linked above. In one’s opinion, the “Ahmed” in these photos is the same person, with a perhaps 10-year gap between the photos. One has no objection to people wishing to change their names — this is simply an interesting item.)

Second, the “presenter” of the “Bird Flu Summit” event, Ginkgo Biosecurity (Ginkgo Bioworks www.ginkgobioworks.com/.) The company’s address and phone number: 27 Drydock Ave., 8th Floor, Boston MA 02210; phone number: 877-HACK-DNA. The company works in “cell programming and biosecurity.” Ginkgo Biosecurity was founded in 2008 by students and scientists at MIT. Two of the founders are Tom Knight (known as the “godfather” of “DNA hacking” and of “synthetic biology” (www.prnewswire.com/news-releases/ginkgo-bioworks-to-become-a-public-company-and-expand-its-leading-platform-for-cell-programming-301288325.html, 11 May 2021; and, Austin Che https://startupexchange.mit.edu/watch/dinkgo-bioworks, 17 July 2017. Mr. Che is also a mentor for Creative Destruction Lab in Toronto, Canada (https://creativedestructionlab.com/mentors/austin-che/.) Below is a screenshot from the Ginkgo BioWorks website:

It appears that Ginkgo BioWorks has quite a bit of funding. Below are screenshots from https://tracxn.com/:

And, some institutional funders:

The United States government is also funding the biosecurity arm of Ginkgo BioWorks: www.dfc.gov/media/press-releases/dfc-approves-11-billion-loan-ginkgo-bioworks-expand-its-commercial-biosecurity, “DFC Approves $1.1 Billion Loan to Ginkgo BioWorks to Expand its Commercial Biosecurity Business to Combat COVID-19 on a Global Scale”, 25 November 2020. DFC is the U.S. International Finance Development Corporation. Below is a screenshot from the article:

For comparison, here is a list of some raw materials used in nucleic acid-based vaccines (mRNA-based vaccines), from www.promega.com/custom-solutions/custom-manufacturing/mrna-manufacturing/:

It would appear that Ginkgo BioWorks was involved in the “rapid deployment” of those PCR tests and antigen tests for COVID-19 at the start of the pandemic; and, also in the production of “two key raw materials for nucleic acid-based vaccines” (the modRNA COVID-19 “vaccines”.) Below is a blog post from April 2020 by Jason Kelly, another Ginkgo BioWorks co-founder, regarding the company’s partnership with Moderna in the production of the modRNA COVID-19 “vaccine”, mRNA-1273, along with other of that company’s mRNA “vaccines”:

Yours Truly has not, to date, found information as to the exact “raw materials” that Mr. Kelly is referring to.

Recall that the NIH/NIAID and Moderna co-developed mRNA-1273, co-own the patents of this modRNA COVID-19 “vaccine”, and share in the “royalty payments” for the sales and administration of this “vaccine” (and its “descendant clone” modRNA COVID-19 “vaccines.”)

Ginkgo BioWorks also “has its fingers in many pies”, including the bio-engineering of elements for gene therapy: www.ginkgobioworks.com/offerings/gene-therapy-services/. One such “service” is the bio-engineering of bacteria for treatment of diseases, such as cancer: www.ginkgobioworks.com/2023/01/09/engineering-bacteria-for-cancer-patient-treatment-with-prokarium/ (Prokarium is another “partner” with Ginkgo BioWorks.) The bacteria to be bio-engineered is a type of Salmonella bacteria, which will be used for “delivery of RNA payloads to treat cancer patients.” (Salmonella is “the most common form of food poisoning the in the U.S.”, according to the Cleveland Clinic. This brings up two questions: One, “Why is a bacteria related to food poisoning going to be used to treat cancer patients?”; and, Two, “How is this Salmonella bacteria going to be bio-engineered — is it going to be “sanitized” to be a beneficial element?”)

In Yours Truly’s opinion, Ginkgo BioWorks is a company to keep “on the radar.” It is acquiring other “partner companies” at a rapid rate. It is expanding its “services” into the gene-therapy sector. It is a “partner” with Moderna (and, therefore, by extension the NIH / NIAID.) In general, one has no objection to a company wishing to increase its profit margin and/or the number of its partner companies; at issue here are the following factors: the bio-engineering of DNA; the use of “automated tools” for engineering / manufacturing “raw materials” for gene-therapy treatments and/or “vaccines”; and the tie-in with the federal government.

General Summary: One: The International Bird Flu Summit was held in Fairfax, Virginia, earlier this month. The general tone of the “summit” was that a “bird flu epidemic / pandemic outbreak” is likely to occur, and soon. Two: The “summit” covered many topics related to epidemic / pandemic response, “command and control” methods, and how “seamlessly” federal, state and local governments and the military can “work together” in the response. Three: the “producer” of the “summit” was SyllabusX, a company that manages events ranging from student security to biosecurity to health education. SyllabusX is based in Virginia. Its Chief Research Officer is Ahmed Al-Faraj, who had previously (apparently) worked for his father’s company, AdvanFort, and (actually) for several other companies. Four: The “presenter” of the “summit” was Ginkgo Biosecurity (Ginkgo BioWorks), a company that offers “services” ranging from commercial biosecurity to bio-engineering to gene therapy research. This company, based in Massachusetts, has “deep funding” from many sources, including from the U.S. government. It has multiple “partners” in R&D, including Moderna. Ginko BioWorks was founded by students and scientists from MIT, including Tom Knight, the “godfather” of “DNA hacking” and of “synthetic biology.” Five: It appears that Ginkgo BioWorks, and, possibly, SyllabusX, are part of what may be called the Big Pharma-Government-Medical Complex (BPGMCTM), the “reach” of which runs far and wide.

Yours Truly will again emphasize the importance of having, and maintaining, the highest degree of health possible of the body’s natural immune system.

Peace, Good Energy, Respect: PAVACA

Health Friday Open Thread 10.04.2024: Self-Amplifying RNA (saRNA) — A Primer on How to Amplify a Disaster

The above image of lab equipment is courtesy of Google Images and Public Domain Pictures.

Today’s offering for Health Friday concerns what is called self-amplifying RNA (saRNA.) As the presentation includes discussion of saRNA COVID-19 “vaccines”, this post is dedicated to the memory of Yours Truly’s cousin Bill, who “died suddenly and unexpectedly” in September 2023.

Readers already know about the Important Wolf Moon Notifications, the importance of Civil Discussion, the Rules of our late, good Wheatie, and the caveats regarding Health Friday posts by Yours Truly. Links to these items can be found here. NOTE: Since this post is detailed and there are multiple areas to cover, Yours Truly has added Summaries of certain sections, and a General Summary at the end.

Before one begins: It is well known that the modRNA and the viral vector COVID-19 “vaccines” currently in use have been, and are, a disaster on multiple fronts. Not only do they induce literally thousands of negative medical and psychological effects in the bodies of those who took them and who take them now; these “vaccines” also cause death. The numbers of COVID-19 “vaccinated” persons presenting with COVID-19 “vaccine”-induced illnesses, injuries, disabilities, or “died suddenly and unexpectedly” are increasing by the month. Nobody knows exactly how long, or in what amount, the elements and mechanisms of the COVID-19 “vaccines” work in the “vaccinated” person’s body: what IS known, is that whatever “protection” is conferred by these “vaccines” is short-lived, while, at the same time, the “vaccine” mechanisms linger on in the body for an indeterminate period of time. Yours Truly has written extensively for this board regarding this situation. For further information, please see websites such as these: https://kirschsubstack.com/ (Steve Kirsch); https://petermcculloughmd.substack.com/ (Peter McCullough, MD); and, https://phinancetechnologies.com/HumanityProjects/Projects.htm#Nav_ExcessDeaths (Ed Dowd, statistician.)

At the same time, the development of new types of COVID-19 “vaccines”, as well as new types of “vaccine delivery” (intranasal, oral, and aerosol, for examples) goes on apace. One of the “newest” types of COVID-19 “vaccines” uses what is called self-amplifying RNA, or saRNA.

The concept of saRNA is the use of a small amount of RNA (or mRNA) in an injectable. Once introduced into the body of the patient, the saRNA theoretically goes to work, “re-creating itself.” (Think RNA or mRNA being turned into a “Xerox copier” inside the “vaccinated” person’s body.) The “goal” of saRNA is for the agent to “re-create itself” inside the “vaccinated” person’s body for a certain amount of time and in some amount. The patient’s body is “instructed” by the saRNA to “recognize” and produce antibodies against certain “enemies”, such as viruses. The theory is that a smaller amount of saRNA initially introduced into the body, followed by the “Xerox copier effect”, then followed by “instructing” the body to “recognize” and fight off certain “enemies”, will make saRNA a “more effective use” of mRNA in injectables.

Basically, saRNA COVID-19 “vaccines” turn the “vaccinated” person’s body into a “Xerox copier” (which, apparently, the “vaccinated” person’s body CANNOT stop, slow down, or mitigate) for the ingredients (and, by extension, the mechanisms) of the saRNA “vaccine.” Today’s post is a primer about saRNA COVID-19 “vaccines.”

The trail begins here, with these: www.science.org/content/blog-post/first-self-amplifying-mrna-vaccine, “The First Self-Amplifying mRNA Vaccine”, 25 January 2024, by Derek Lowe; https://jessicar.substack.com/p/why-we-cant-move-forward-with-self. “Why we can’t move forward with self-amplifying RNA technology”, by Jessica Rose, PhD, 7 September 2024; www.2ndsmartestguyintheworld.com/p/japans-plan-to-destroy-the-world, by Daniel Nagase, MD, 10 September 2024; and, www.freethink.com/health/sarna-vaccines, “World’s first “self-amplifying” vaccine approved in Japan”, by Kristin Houser, 16 December 2023. Please look at any or all of these to gain information about saRNA “vaccines.”

In addition, there is Dr. Robert Malone’s take: please see: https://x.com/newstart_2024/status/1840796021166600635. Below are screenshots of his remarks:

There are “pros and cons” regarding the use of saRNA in injectables. Below, from an article that discusses these, via www.promegaconnections.com/how-do-self-amplifying-vaccines-work/, by Jordan Nutting, 6 February 2024:

****** Summary: In other words, saRNA injectables **may**, at some point down the road, have **some** benefits. In the meantime — NONE of these types of injectables (GEMCOVAC, Kostaive) have been SUFFICIENTLY AND THOROUGHLY INVESTIGATED AND TESTED FOR USE ON HUMANS. But they are being approved ANYWAY, and are being injected into the bodies of unsuspecting persons who buy into the “Look, this shot has less mRNA than the ones you took before, and it’ll work better!” hype.

Here is a graphic depicting how saRNA works in the body of the person who is “vaccinated” with an saRNA injectable, via this “cheerleader” article: www.genscript.com/the-future-of-vaccination-unleashing-the-power-of-self-amplifying-rna-technology.html, by Dr. Zhen Sun, Editor, 9 May 2024.

****** Look closely at the above graphic. It appears that the basic schema of saRNA is a “double-layer” of saRNA “replicons” that create a “subgenomic RNA.” This, in turn, creates the “Xerox copier” response which forces the body of the saRNA “vaccinated” person to endlessly produce immune system response — and for “at least” as long as 28 days after such “vaccination.”

Please see this paper regarding a discussion of saRNA “vaccine” design: https://doi.org/10.1016/j.tibtech.2023.05.007, “Rise of the RNA machines — self-amplification in RNA vaccine design”, Jerome D.G. Comes, et al., 14 June 2023. Below is the Abstract of this paper:

Another “cheerleader” article about saRNA “vaccines” is here: www.technologyreview.com/2024/02/1087536/the-next-generation-of-mrna-vaccines-is-on-its-way/, by Cassandra Willyard, February 2024. Below is a portion of the article:

Note the language about “,…at least in theory” advantage of saRNA “vaccines.” Also note the last sentence — saRNA can “persist for a month.” In fact, nobody really knows how long saRNA elements will “persist” in the body of the person who takes this type of “vaccine” — NO long-term clinical trial or study has been performed using this technology.

On 28 November 2023, the Japanese Government approved the use of the saRNA COVID-19 “vaccine”, ARCT-154 (also called LUNAR-COVID-19 and Kostaive) for “active immunization” (translation: “prevention”) against COVID-19 for persons age 18 and older. Kostaive was developed by CSL / Arcturus (remember this company? Yours Truly took the lid off it here: www.theqtree.com/2024/08/02/the-hhs-gave-the-go-ahead-to-use-an-h5n1-vaccine-but-the-ama-just-issued-new-cpt-codes-for-an-h5n8-vaccine/.) This “vaccine” was to have supplies ready for administration by physicians or hospitals by mid-December 2023.

CSL / Arcturus, the Japanese government, and media outlets were quick to herald this “first-ever saRNA COVID-19 “vaccine.” Except — there already was an saRNA COVID-19 “vaccine” approved and in use, since 2022, in India: GEMCOVAC. Perhaps what CSL / Arcturus, the Japanese government, and media outlets should have mentioned the fact that Kostaive is modRNA-based from the J.1. Omicron SARS-CoV-2 variant (along with other “familiar” manufacturing methods, see below in today’s post); whereas GEMCOVAC based on an “ancestral variant” (in other words, the Beta variant) of the original Wuhan Hu1 SARS-CoV-2 virus.

Before Yours Truly presents information on Kostaive, she will first discuss GEMOCOVAC. This is in order to present further background information on saRNA technology as applied in COVID-19 “vaccines.” Stay with me — this is all germane to the situation:

Looking at GEMCOVAC, one can get the beginning of a picture of how saRNA COVID-19 “vaccines” work. The “latest version” of this “vaccine” is called GEMCOVAC-OM. Below is a portion of the SmPC pdf for this product (https://gemcovac.com; scroll down the page to GEMCOVAC-OM SmPC (pdf) and click “Download”):

The BA.1. Omicron variant of SARS-Co-V-2 is the basis for this “vaccine.” It is not strictly modRNA (however, recall that ALL of the “descendant variants” of the original Wuhan Hu1 SARS-CoV-2 virus contain elements of that original lab-created virus).

Of the excipients (in other words, the adjuvants): per Wikipedia, DOTAP (1,2-Dioleoyl-3-trimethylammonium propane) is a chemical used in fabric softeners, but also is used as a lipid nanoparticle in vaccines. Squalene: below is Page 1 of the FisherScientific MSDS Safety Data Sheet for this chemical (www.fishersci.com/):

Continuing: for polysorbate 80, again from Fisher Scientific, Page 1 of the MSDS Safety Data Sheet:

And, here is the Mechanism of Action for GEMCOVAC-OM, from the Package Insert (see the link above):

Note the language, “…which is reported to interact with host cells receptors (ACE-2.)” (Italics mine.) The developer and manufacturer (GENNOVA) of this “vaccine” can’t exactly quantify how the product works.

Yours Truly now turns to Kostaive, (ARCT-154) the saRNA COVID-19 “vaccine” that was approved by the Japanese government in November 2023.

The announcement regarding the Japanese government’s approval of Kostaive is here: www.meiji-seika-pharma.com/pressrelease/2023/detail/pdf/231128_01.pdf, of 28 November 2023. Below is a screenshot from the press release:

Note the language in the above regarding “…the potential for extended duration of protection while using lower doses of mRNA compared to existing mRNA vaccines.” (Italics mine) Again, nobody knows exactly how long this “extended duration” period is; nobody knows exactly how much “Xerox copying” of the altered mRNA in Kostaive occurs during this period in the “vaccinated” person’s body; and, nobody knows exactly what effects this “Xerox copying” of the altered mRNA in Kostaive will have in the “vaccinated” person’s body. In other words, anyone who takes Kostaive, or any saRNA “vaccine”, in Yours Truly’s opinion, is being used a “human lab rat” — just as people were used / are still being used, as “human lab rats” for the modRNA COVID-19 “vaccines.”

And, here is the Report of the Deliberation Results (which contains the information about Kostaive that led to its approval) from the Japanese Ministry of Health, Labour, and Welfare: www.pmda.go.jp/files/000269813.pdf. This report is an interesting read. There are numerous “blacked-out” areas, reminding one of the blacked-out areas in certain publicly-released Pfizer-BioNTech reports that the company gave to the FDA regarding that company’s modRNA COVID-19 “vaccine” BNT162b2. HOWEVER, section 2.1 Active Substance for Kostaive states that this saRNA “vaccine” contains elements from the original Wuhan Hu1 SARS-CoV-2 virus, plus elements from the Omicron variant strain. More information on this is found on Page 4 of the document. Below is a portion of this page:

Looking at the above, starting with the D614G mutation, the Abstract from the Zhang, et al. paper on this (https://doi.org/10.1038/s41467-020-19808-4, “SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity”, Lizhou Zhang, et al., 26 November 2020. The paper was researched and published before any COVID-19 “vaccine” was authorized for use):

In other words, the D614G element causes the SARS-CoV-2 virus to be more infective.

Looking at V987P, part of the section Full-Length S Glycoprotein Vaccines from this paper: https://doi.org/10.3389/fimmu.2021/701501, “SARs-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants”, Daniel Martinez-Flores, et al., 11 July 2021):

In other words, if V987P was “good enough” for Pfizer-BioNTech and for Moderna to use in their modRNA COVID-19 “vaccines”, it apparently was “good enough” to be used in Kostaive.

The K986P protein used in Kostaive: please see here: www.rcsb.org/structure/6zp1. This viral protein, along with V987P above, are BOTH on the Arg S1/S2 cleavage site on the SARS-CoV-2 virus genome. (FURIN CLEAVAGE SITE, anyone?)

The R682G, R683S, and R685S proteins used in Kostaive: please see here: https://doi.org/10.1038/s41467-022-32665-7, “Omicron SARS-CoV-2 mutations stabilize spike-up RBD conformation and lead to a non-RBM-binding monoclonal antibody escape”, Zhennan Zhao, et al., 24 August 2022. If appears that these proteins help to create a “one-RBD-up conformation.” Below is a portion of the Abstract of this paper:

In other words, these proteins increase the immune system attack from the Omicron SARS-CoV-2 variants by making Omicron “stick better” to the ACE2 receptor cells in the human body.

****** Summary: It appears, then, that Kostaive contains one protein from the original Wuhan Hu1 SARS-CoV-2 virus genome (D614G); two proteins from the “ancestral line” of the SARS-CoV-2 virus (K986P and V987P); and three proteins of the Omicron SARS-CoV-2 variant (R682G, R683S, and R685S.) See below in the post for more information on these items.

One more ingredient of Kostaive, mRNA-2105: This ingredient is derived from the Venezuelan Equine Encephalitis virus (VEEV.) Below is section 4.R.1. of the Deliberations Results document discussing this:

The question that immediately occurs regarding the above: How can Arcturus (the manufacturer of Kostaive) state that mRNA-2105 cannot be “incorporated into host cell DNA”? How is Arcturus absolutely sure that there is zero reverse transcription potential or ability in Kostaive? This is similar to the same statements from Pfizer-BioNTech about BNT162b2 “cannot change the DNA of the vaccinated individual” — which has been proven to be false (please see: here, Slide 14.)

****** Summary of the above: What Yours Truly is getting at here is that Kostaive appears to be the end-product of: ONE: a lab-created mixture of the dangerous D614G element from the original Wuhan Hu1 SARS-CoV-2 virus, plus, various elements of earlier SARS-CoV-2 mutations; TWO: NO long-term clinical trials, NO safety studies for Toxicity, use on pregnant women, etc.; THREE: the “Process 2”-type manufacturing method (“culturing” the lab-enhanced mRNA for the “vaccine” in a “bath” of E. coli); FOUR: using lipid nanoparticles, one of which (ATX-126) has never been used before in an injectable); FIVE: what appears to be a “pro-forma” Deliberation Results document on Kostaive that raises more questions than it answers; and, SIX: approval by the Japanese government for use on humans without a thorough investigation of the above. Related to point SIX: below is the list of Approval Conditions that were imposed along the approval of Kostaive for use in Japan, from the Deliberations Results document:

By the way, these Approval Conditions read very much like the ones that the FDA imposed on Pfizer-BioNTech along with that agency’s EUA for BNT162b2.

Regarding Kostaive itself, more particulars:

The ingredients of Kostaive are listed in section 2.2 Vaccine Product of the report. A screenshot of this section is below:

Kostaive contains at least three separate types of LNPs (lipid nanoparticles): ATX-126; DSPC; and, PEG2000-DMG. Below is a portion of the MSDS Safety Data Sheet for ATX-126:

Section 2.2.3 of the Deliberation Results document for Kostaive discusses the manufacturing process for Kostaive. It appears that Kostaive ALSO “switched” from a “Process A” manufacturing method over to a “Process B” manufacturing method. (Recall that the Pfizer-BioNTech BNT162b2 was “switched” from its “Process 1” manufacturing method over to a “Process 2” manufacturing method):

One more item from the Deliberation Results document for Kostaive, again on the ATX-126 lipid nanoparticle used in this “vaccine.” It confirms that this “novel excipient” (adjuvant) has not been used before in a “vaccine.”

Yours Truly will again emphasize that other sections of the Deliberation Results document on Kostaive make it clear that NO studies were performed for numerous items, such as Toxicity, potential for impairment of reproduction, and so on. By the way, buried in the document is a “passing reference mention” that the “Process B” manufacturing method for this “vaccine” uses E. coli as the “culturing medium” for the “enhanced” mRNA in the product. (The “Process 2” manufacturing method for BNT162b2 and its “descendant” COVID-19 “vaccines” also uses E. coli.) It also appears that the use of Kostaive on pregnant women in clinical trials was “inconclusive”; this “vaccine” should be taken by pregnant women only if the situation so warrants.

Also: Kostaive is to be taken as a “primary series” of two separate injections, 28 days apart; with a “booster” taken about three months later. The question that arises is: If it is true that the saRNA in Kostaive is active, including installing numberless “Xerox copiers” of itself in the “vaccinated” person’s body for AT LEAST 28 days AFTER the initial injection, WHY is there a need for ANOTHER injection around Day 28? And a “booster” after that?

****** BUT — AND THIS IS A HUGE BUT — TAKE ANOTHER LOOK AT SECTION 2.2.1 OF THE DELIBERATION RESULTS DOCUMENT FOR KOSTAIVE:

Look at the “active ingredient” item, “zapomeran.” What is zapomeran? It is a “drug” that contains the RNA of the Venezuelan Equine Encephalitis Virus (VEEV or VEE) in an saRNA form. It is ALSO manufactured by ARCTURUS (CSL.) It is unclear if it is being used in other types of COVID-19 “vaccines” other than Kostaive. Please see: https://synapse.patsnap.com/drug/510bcf7ef75649278b284a94663c69f6. Scroll down the page to R&D Status to see that zapomeran has already been approved in the EU; Norway; Iceland; and Liechtenstein; but in what final form it is used, is also unclear. NOTE 1: It has been impossible to find a complete list of ingredients for zapomeran. One would not be surprised to learn that the names Kostaive and zapomeran may, in some respects, be “interchangeable.” NOTE 2: It is not easy to find information on zapomeran. Yours Truly has encountered “504 Bad Gateway” error messages when going back to recheck a couple of the links to zapomeran in this post.

Looking further into VEEV (or VEE), there is this article: https://ceh.vetmed.ucdavis.edu/health-topics/venezuelan-equine-encephalitis-vee, by Amy Young, 28 August 2020. This virus can affect horses, donkeys, or zebras. VEEV is transmitted to these animals by infected mosquitos that bite them. It can cause severe disease or death by infecting the brain and the central nervous system. Humans who contract VEEV can also become severely ill and can also die from it. Another paper, discussing the RNA of VEEV (VEE),by Sarah E. Hickson and Jennifer L. Hyde, is here.

As an aside: zapomeran (under the name “ARCT-154-06”) was granted a “deferral” for use on children from birth to 18 years of age in the European Union for the “prevention” of COVID-19 infection in JUNE 2023: www.ema.europa.eu/en/documents/pip-decision/p-0204-2023-ema-decision-5-june-2023-agreement-paediatric-investigation-plan-granting-deferral-zapomeran-emea-003349-pip01-22_en.pdf. This means that the use of zapomeran (in whatever form) is restricted to persons age 18 and older.

AND HERE IS THE JAPANESE NIHS LISTING FOR ZAPOMERAN: https://jpdb.nihs.go.jp/jan/DetailList_en?submit-all_alpSearch&keyword=Zapomeran. Below is a screenshot of the listing (scroll down past the genome sequences listings):

****** VERY IMPORTANT: The SARS-CoV-2 spike proteins in zapomeran are the same ones that are in Kostaive. These were discussed above in the post. Turning to the nsP proteins (non-structural proteins) in zapomeran (hyperlinks to papers are embedded), as these elements are also apparently contained in Kostaive:

nsP1: this non-structural protein suppresses the immune system; Katharina Schubert, et al.

nsP2: this non-structural protein is a “delivery vehicle” for SARS-CoV-2 proteins; Ninge Zheng, et al.

nsP3: this non-structural protein is a “vital component in the replication of SARS-CoV-2”; Sofia Lemark, et al.

nsP4: this non-structural protein is the largest one. It is a Rotavirus enterotoxin that causes diarrhea, can cause severe diarrhea, and particularly affects young children; Judith M. Hall, et al.

****** SUMMARY: IT APPEARS, THEN, THAT KOSTAIVE CONTAINS ZAPOMERAN, WHICH INCLUDES THE VENEZUELAN EQUINE ENCEPHALITIS RNA; PLUS, SIX LAB-ENHANCED/LAB-ISOLATED GENOME CODES OF SARS-CoV-2; AND, FOUR NON-STRUCTURAL PROTEINS, ONE OF WHICH IS A ROTAVIRUS TOXIN. KOSTAIVE ALSO CONTAINS DANGEROUS LIPID NANOPARTICLES (SUCH AS ATX-126.) THESE ARE ALL PRESENT IN THIS saRNA COVID-19 “VACCINE” PRODUCT. RECALL THAT LIPID NANOPARTICLES WILL HELP TO SPREAD A “VACCINE” THROUGHOUT THE ‘VACCINATED” PERSON’S BODY, INCLUDING CROSSING THE BLOOD-BRAIN BARRIER.

Why on Earth is a COVID-19 “vaccine” that contains the RNA of an equine brain inflammation virus (a virus that comes from infected mosquitos that bite equine animals) being used on humans? A “vaccine” that is engineered to create an unknown number of “Xerox copiers” of the “vaccine” elements into the body of the “vaccinated” person? A “vaccine” that contains six apparently lab-enhanced/lab-isolated genome codes from the SARS-CoV-2 virus or its variants? What does an equine brain inflammation virus have in common with SARS-CoV-2? What if a person who has already taken, say, five or six injections of a modRNA COVID-19 “vaccine” decides to take Kostaive? Could an saRNA COVID-19 “vaccine” somehow “interact” with the modRNA COVID-19 “vaccine” elements already in that person’s body?

****** GENERAL SUMMARY: saRNA “vaccines” for COVID-19 are already being used (GEMCOVAC in India); and are being approved for use (Kostaive in Japan.) The technology for saRNA is not fully developed and not fully tested; the COVID-19 “vaccines” that use saRNA contain “lab-enhanced”/”lab-isolated” genome codes of the SARS-CoV-2 virus or its variants; saRNA COVID-19 “vaccines” contain lipid nanoparticles — and, in the case of Kostaive, an LNP (ATX-126) that has never been used before in an injectable; that no studies have been performed on saRNA COVID-19 “vaccines” regarding Toxicity, the effects on reproductive potential, and so on; and, that Kostaive contains the RNA of the Venezuelan Equine Encephalitis Virus. And yet, these products are being hailed as “the vaccines of the future.” And, the people taking them are again being used as “human lab rats.”

Peace, Good Energy, Respect: PAVACA

Health Friday Open Thread 9.27.2024: Another Scientific Paper Is Under Attack For Telling The Truth About The COVID-19 “Vaccines”

The above image from an old medical-scientific journal is from PeopleImages, via Google Images.

This post is part of Health Friday, a series of offerings related to Big Pharma, vaccines, general health, and associated topics. The discussion is not limited to what is presented today; it is an Open Thread. However, since this presentation is about a COVID-19 “vaccine”, the post is dedicated to the memory of Yours Truly’s cousin Bill, who died “suddenly and unexpectedly” in September 2023.

To begin, there are Important Wolf Moon Notifications, with a couple of extra items:

Free Speech is practiced here: “Use it or lose it.”

The following are alternate Q Tree sites for certain circumstances:

The U Tree is for “argue it out” interactions. There is a “Featured” article at this site for use as a “Rescue Thread.”

The “third site”, in case the above two are inaccessible.

Civil discussion is practiced here. The excellent and timely Rules of our late, good Wheatie prevail:

One: No food fights.

Two: No running with scissors.

Three: If you bring snacks, bring enough for everyone.

Please follow the added Guidelines from Wolf Moon. Please do not give the modern-day version of Cato the Elder the opportunity to show “enmity” to the board.

The extra items: What Yours Truly presents in this series, as in her other blog posts to this board, is not medical advice — the are opinions and hypotheses based on her over 4 1/2 years (and continuing) of reading about, researching out, and writing about “all things COVID”, Big Pharma, and other health topics. Readers are encouraged to consult a healthcare practitioner regarding health concerns or conditions.

The Health Friday post today concerns the impending Retraction of a peer-reviewed and published paper that details long-term COVID-19 “vaccine”-induced injuries in North India. The paper was submitted to Springer for review and publishing on 9 January 2024; it was accepted (it had passed the peer-review process); and it was published on 13 May 2024. Here is a free-access version (to read the entire paper on Springer, one has to either access through an institution, or to pay for a copy): www.qeios.com/read/JK7IBA/pdf, “Long-Term Safety Analysis of the BBV152 Coronavirus Vaccine in Adolescents and Adults: Findings from a 1-Year Prospective Study in North India”, Upinder Kaur, et al., 13 May 2024. The study was conducted at Banaras Hindu University in India. BBV152 is another name for the COVAXIN COVID-19 “vaccine”, developed by Bharat BIotech of India in cooperation with Indian Council on Medical Research (ICMR) – National Institute of Virology. ICMR receives “royalty payments” for each dose of COVAXIN that is administered, as does Bharat Biotech (Sound familiar? — as in, the co-development, co-ownership of patents, and sharing of “royalty payments” between the NIAID and Moderna for the modRNA COVID-19, mRNA-1273?)

For purposes of today’s offering, the trail begins here: https://blog.maryannedemasi.com/p/breaking-journal-pressured-to-retract, 23 September 2024. Dr. Demasi has a PhD in Rheumatology from the University of Adelaide (Australia.)

The Kaur, et al., paper referenced above was published by Springer on 13 May 2024. Almost immediately, the attacks began on the paper, the authors, and the publisher — with articles like this one: https://timesofindia.indiatimes.com/india/1-in-3-covaxin-recipients-hit-by-adverse-events-study/articleshow/110187284.cms, “1 in 3 Covaxin recipients hit by adverse events: Study”, 17 May 2024. On 18 May 2024, the ICMR demanded that Springer retract the paper (Yours Truly: nothing like causing panic in a government agency when the truth is published about a “vaccine” that the agency is pushing as “safe and effective,” especially when that agency is also getting “royalty payments” for the use of the “vaccine”, is there?). But, the attack on Springer and the authors didn’t end there. In July 2024, Bharat Biotech filed a lawsuit against Springer and the authors (some of the authors are students), demanding retraction of the paper and the payment of damages to Bharat Biotech of $600,000 US dollars (50 million Indian rupees.) In addition, the lawsuit accused the paper’s authors of defamation against the company, included with a demand for separate damages to be paid to the company for defamation. Despite sworn statements from the authors that no defamation was intended or written into the paper; and, despite the fact that Nitin Joshi, the editor of the Springer journal (Drug Safety) in which the study appeared, was one of the reviewers who approved the study for publishing, it was Joshi who notified the authors on 28 August 2024 that he was going to have the paper retracted. He confirmed this decision in an email to the authors on 17 September. However, as the defamation lawsuit is now in court, the study is still available on the internet.

What is BBV152/COVAXIN? It is an “inactivated whole virion vaccine” (whole virus vaccine) for “active immunization” against COVID-19. It is not an mRNA-based/modRNA-based COVID-19 “vaccine”, although it does use an “ancestral wave strain” of the original Wuhan Hu1 SARS-CoV-2 virus (in other words, a strain from the Wuhan Hu1 virus that occurred before the Beta, Delta, or Omicron strains.) The Package Insert for COVAXIN is here: www.bharatbiotech.com/images/covaxin/covaxin-pack-insert.pdf. Below is an image from the Package Insert:

Per Wikipedia, 363,774,435 persons in India had been “vaccinated” with at least one dose of COVAXIN as of 4 March 2023.

However, the COVAXIN Package Insert does not actually describe how the “vaccine” works (the “Mechanism of Action.”) Yours Truly found something along the lines of the necessary information here: www.clinicaltrialsarena.com/projects/covaxin-bbv152-for-the-treatment-of-covid-19/?cf-view&cf-closed, “COVAXIN (BBV152) for the Treatment of Covid-19, India”, 28 June 2022. Below is a screenshot from this article:

But, COVAXIN has been hailed by the Indian government about being “the first indigenous COVID-19 vaccine in India” (www.bharatbiotech.com/covaxin.html.) Why is ViroVax involved? (More on this later in the post.) Back to the Package Insert for COVAXIN. Below is a screenshot of the ingredients used in this “vaccine”:

Looking further into the ingredients list, starting with the NIV-2020-770 strain of SARS-CoV-2: please refer to this paper: www.ncbi.nlm.nih.gov/pmc/articles/PMC7825810/, “Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised Phase 1 trial”, Krishna Mohan Vadrevu, et al., May 2021. It appears that NIV-2020-770 (the “inactivated whole virion”) is part of the Asp614Gly variant chain of the SARS-CoV-2 virus. The Asp614Gly variant itself is apparently part of the “ancestral wave” of the original Wuhan Hu1 SARS-CoV-2 virus; and, it is “not as serious” as the Beta or the Delta waves of the virus. Please refer to this article: www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(22)00199-1.pdf, Vol.10, July 2022, a Comment “Decoding the next SARS-CoV-2 variant”, by Jeremy Nel and WD Francois Venter. Below is a screenshot of a portion from the Comment:

Thus, BBV152/COVAXIN cannot be considered to be one of the “most recent” types of COVID-19 “vaccines”, as it does not include any elements before the Beta, Delta, or Omicron variants.

The Aluminium Hydroxide Gel in the ingredients (it is an “excipient” [“adjuvant]”): this is also called “Algel-IMDG” and “Alhydroxiqium-II” — in other words, it is a hydrogel. It was invented by ViroVax LLC of Lawrence, Kansas, under the aegis of the EpscoR Idea Foundation (part of the National Science Foundation in the United States), and with funding by the NIAID. This is the ViroVax / United States government connection. Here is a screenshot from an article by the EpscoR Idea Foundation on this “success story” (www.epscorideafoundation.org/success-stories/kansas-adjuvant-developed-with-nih-funding-enhances-efficacy-of-indias-covid-19-vaccine):

Note that Alhydroxiqium-II targets the lymph nodes of the person who takes COVAXIN. So, while this excipient is not exactly a lipid nanoparticle (LNP), it, in Yours Truly’s opinion, basically functions like an LNP in targeting the lymph nodes for delivery of the “vaccine payload” of COVAXIN; and, by “stimulating” the “vaccinated” person’s natural immune system to go and “search” for invading pathogens. By the way, Aluminium Hydroxide Gel is not to be used in foods, drugs pesticides, or “biocidal” products — see the screenshot below, from the search on Fisher Scientific (ThermoFisher) about this chemical, Page 1:

HOWEVER, it appears that FisherScientific had a “change of heart” since December 2021 regarding the “Uses advised against” for Aluminium Hydroxide — below is their MSDS Safety Sheet as of February 2024, Page 1:

Here is another source for an MSDS Safety Sheet, this one specifically for Aluminium Hydroxide Gel: www.oxfordlabfinechem.com/msds/ALUMINIUMHYDROXIDEGEL.pdf. Please see section 3 Hazards Identification; and section 11 Toxicological Information Special Remarks on Other Toxic Effects on Humans. Below is part of the Special Remarks portion of section 11:

The TLR7/8 excipient (adjuvant) in COVAXIN: This one is used in immunotherapy, including in the treatment of HIV-1. Please see: https://doi.org/10.3389/fmicb.2023.1033448, “Novel TLR7/8 agonists promote activation of HIV-1 latent reservoirs and human T and NK cells”, Yangyang Li, et al., 26 January 2023. This begs the question, Why is an HIV-1 immunotherapy treatment element being used in a COVID-19 “vaccine?” This also, in Yours Truly’s opinion, removes any consideration of COVAXIN to be labeled a “vaccine” — it is actually a gene therapy/immunotherapy injectable.

And, the 2-Phenoxyethanol excipient (adjuvant) in COVAXIN. Below is a screenshot portion of the Fisher Scientific (ThermoFisher) MSDS Safety Sheet for this chemical, Page 1:

The Kaur, et al., paper, goes into detail regarding the types of reported serious adverse events that affected the study subject pool who took COVAXIN. Three pages of the Supplementary Table 1. from the paper are below. Note that these are details from subjects one year after “vaccination” with COVAXIN. Note also that another paper from December 2020 (by different authors) shows that the S1 protein of the SARS-CoV-2 virus itself crosses the Blood-Brain Barrier.

If Yours Truly is reading about this situation correctly, it appears that one of the “problems” with the Kaur, et al., paper, is that the subject pool of COVAXIN-“vaccinated” persons in North India who reported serious adverse events following “vaccination” to the study authors was “small.” One has to ask: How many COVAXIN-“vaccine”-induced serious adverse events would need to be reported before they would be considered “relevant” by the Indian government and by Bharat BioTech? — say, a “minimum” of 3 million adverse events reports? Is it “within acceptable limits” that COVAXIN-“vaccinated” persons in North India suffer a stroke or a heart attack after “vaccination” with this product? Is this another situation of “the known and potential benefits outweigh the known and potential risks” of taking a COVID-19 “vaccine”, which is the “official” position of the CDC and the FDA in the United States?

Yours Truly has gone into detail regarding the situation with BBV152/COVAXIN for several reasons: First, to enumerate the multiple potentials for “vaccine”-induced serious adverse effects from this COVID-19 “vaccine” product; Second, to highlight the persecution of the authors of a paper who sought to study and write about these potentials; Third, to highlight the persecution of the journal that peer-reviewed, approved, and published the paper; Fourth, to bring to light the involvement of the United States government (via the NSF and the NIAID) in the funding and development of an ingredient (excipient/adjuvant) in this “vaccine” intended for use in a foreign country; and, Fifth, to again emphasize how important it is that consumers “do their own due diligence” regarding information on drugs and/or injectables that they put into their bodies.

Peace, Good Energy, Respect: PAVACA

Health Friday Open Thread 9.20.2024: Double-Expose’ Edition

The above is a vintage image of Dr. Edward Jenner administering the first smallpox vaccination (inoculation) to James Phipps, 14 May 1796. Courtesy of www.sciencemuseum.org.uk/.

Today’s post, as it relates to the disaster of COVID-19 and the COVID-19 “vaccines”, is dedicated by Yours Truly in memory of her cousin Bill, who died “suddenly and unexpectedly” in September 2023. However, the discussion is not limited to what is presented here: it is an Open Thread.

There are two separate, although connected (Big Pharma), parts to today’s offering. Each part is of itself an expose’. This post is a long one, but important. Please, take a cup of coffee or tea; or, if it’s an appropriate time of the day, perhaps a “wee dram” of something like chilled D.O.M. Benedictine with a twist of lemon peel, and settle in for reading.

Readers already know the caveats regarding civil discussion on this board; of the alternate sites in case the main board is not accessible (here and here); and, that what Yours Truly presents on Health Friday is not medical advice, but opinions and/or hypotheses from ongoing research on COVID-19, Big Pharma, and other health topics.

“Quick, down-and-dirty summary” of today’s post:

One: Pfizer-BioNTech has begun a new enterprise, PfrizerForAllTM, which apparently seeks to completely circumvent / marginalize, in-person consumer contact with pharmacies; to “funnel” in-person consumer contact with healthcare practitioners to “Pfizer-affiliated” professionals; and, to “redirect” the dissemination of information about the COVID-19 “vaccines” to that provided by Pfizer-BioNTech.

Two: That the FDA approval of the very dangerous and deadly Smallpox “vaccine”, ACAM2000, for use also as a “prevention” for Mpox, is the result of a complex mixture of Big Pharma influence + FDA review of the Biologics License Applicaion for this use of ACAM2000 that is, in Yours Truly’s opinion, “a foregone conclusion despite serious reservations”, to say the least + Gain-of-Function experiments on the Mpox virus. There is also a potential tie-in to “an expanded biodefense role.”

Yours Truly has tried to avoid making today’s post read like a scientific paper; however, there is a lot of information that is relevant to each Expose’. Note: Mpox is now the “official” name for monkeypox.

Expose’ One: It appears that Pfizer-BioNTech is creating new ways to increase the company’s consumer operations (and, therefore, potential profit lines.) Pfizer-BioNTech has just launched PfizerForAllTM — a direct sell-to-consumer business that will provide online access to healthcare providers (online [virtual], or affiliated healthcare providers encounters [for example, to get a COVID-19 “vaccination”]); plus, “delivered to your door” prescription drugs and “easier access” to other company products, such as their COVID-19 “test kits.”

The story begins here: https://sashalatypova.substack.com/p/pfizers-vaccine-business-is-so-pfucked, 7 September 2024. From the blog article, below:

Pfizer-BioNTech filed a Trademark Application in May 2024 for this new PfizerForAllTM program https://endpts.com/pfizer-submits-trademark-application-that-suggests-it-could-be-launching-a-direct-to-patient-program/, 13 May 2024, by Nicole De Feudis. (One must be a subscriber in order to read the entire article.) It appears that the application was approved: the company officially launched the program on 27 August 2024 (from the article on www.businesswire.com/, Pfizer Launches PfizerForAllTM, a Digital Platform that Helps Simplify Access to Healthcare (www.pfizerforall.com/.) From the article:

In other words, in Yours Truly’s opinion, Pfizer-BioNTech, not happy with the company’s portfolio loss due to falling consumer acceptance of the modRNA COVID-19 “vaccines” offered, and due to the failure of the company’s clinical trial of its “combo” modRNA COVID-19 “vaccine” + influenza “vaccine”, a corporate decision was made to find a way to go straight to the consumer and make it “so easy” to get access to the “vaccines”, plus other Pfizer products. Translation: banish “vaccine” hesitancy / “vaccine” refusal, by doing what may be called “straight to the consumer medical psy-op.” Again, from the Latypova article:

Dr. Peter McCullough’s take on the Pfizer-BioNTech move is here: https://petermcculloughmd.substack.com/p/pfizer-launches-pfizerforall, 14 September 2024. Below is a portion of his article:

The lawsuit that Pfizer-BioNTech settled in 2009 was over the use of the company’s drug, Bextra, in “off-label” situations. The scope of the settlement is described here: www.justice.gov/, “Justice Department Announces Largest Health Care Fraud Settlement in Its History”, 1 November 2023. A portion of the announcement is below:

This lawsuit was the starting point for FDA changes to its “regulations” regarding the use of prescription drugs in “off-label” situations. The latest FDA changes are summarized here: www.sidley.com/en/insights/newsupdates/2023/11/fda-s-latest-off-label-guidance, 1 November 2023. It appears, in a nutshell, that drug manufacturers can be held responsible (liable) for “off-label” use of their products, even if they already comply with the “new” FDA “regulations.” (Think of this in light of the use of, for example, Ivermectin or Hydroxychloroquine to prevent or to treat COVID-19 — these uses, arguably, are “off-label” for these drugs.)

By the way, PfizerForAllTM is working with UpScript Health and Alto Pharmacy regarding access to healthcare services and filling prescriptions. Guess what? UpScript Health lists Pfizer as a “partner” on the company’s “About” page of their website: www.upscripthealth.com/about/. And, there’s more — Alto Pharmacy, the online prescription drug company, has a couple of interesting members on their Board of Advisors: Alex Azar (HHS head under then-President Trump); and, Dr. Ezekiel Emanuel (he who helped to write the “ObamaCare” bill; he who advocated for people to take their own lives at age 75 “to make room for the younger generation”, and more): www.alto.com/our-company. Dr. Emanuel is also involved with the Center for American Progress (Soros-connected: www.americanprogress.org/c3-our-supporters/); The Aspen Institute; and, he is Co-Director of the Healthcare Transformation Institute (HTI) at the University of Pennsylvania. Below is the Mission statement of HTI (https://hti.upenn.edu/mission/):

Note 1: the “objective” to transform the behavior of physicians and other healthcare providers. (Italics, mine.) Note 2: the “imagifashion” hyperlink, apparently, after getting past the “fake Latin language” on the main page, takes one to a clothing/accessories company in California: https://nilah.la-studioweb.com/contact-us/. (??)

Regarding Alto Pharmacy, please see here: www.fiercehealthcare.com/health-tech/track-soon-hit-1b-revenue-alto-pharmacy-tapped-amazon-exec-its-next-phase-growth, 17 August 2022. Here’s what one needs to know about the “mission” of Jamie Karraker and Matt Gemache-Asselin, the company’s co-founders:

This statement really frosts Yours Truly. My late father was a Registered Pharmacist for 57 years, who: kept his pharmacy very clean and neat (one was part of the crew that swept the floors and cleaned the display shelves starting when she was 10 years old); made it a point to know about all of his patients and to TALK with with then they came to have prescriptions filled or refilled; worked out deals with his suppliers to get extra samples of OTC products to give to his patients who had lost their steel mill jobs when the mills left Pittsburgh in the late 1970s-early 1980s, and, who paid for their prescriptions with his own money at times, etc., — finds the language, “…brick-and-mortar terrible experience…” in the above statement not only to be personally insulting to the memory of her father: but, also, degrading to those “brick-and-mortar” pharmacists who do their job to keep their stores clean and organized.

Expose’ Two: This regards the FDA just “approving” the “expanded use” of the dangerous and deadly Smallpox “vaccine”, ACAM2000, for the “prevention” of Monkeypox (now called “Mpox.”) The FDA issued this “approval” on 29 August 2024. The trail on this begins here: https://mole.substack.com/p/acam2000-package-insert-warning-death, 14 September 2024.

To gain more understanding of Smallpox and inoculation / vaccination against Smallpox, please see: www.sciencemuseum.org.uk/objects-and-stories/medicine/smallpox-and-story-vaccination. Both Smallpox (variola) and Mpox (mpox virus) are members of the genus Orthopoxvirus. Whereas, a disease condition that would equate to Smallpox goes at least as far back as to China around 3000BC, Mpox was first discovered in 1958 (all, per Wikipedia search.) Dr. Edward Jenner, an English physician, noticed that milkmaids were immune from Smallpox infection; he deduced that the Cowpox infections that they sustained had made them immune to the other type of infection. Dr. Jenner administered the first “inoculation” of Cowpox virus (to prevent Smallpox) to a child, James Phipps, on 14 May 1796. Another source of information is here: wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/smallpox-and-other-orthopoxvirus-associated-infections. Further details are found here, in the article, Edward Jenner and the history of smallpox and vaccination, January 2005. A screenshot of a portion of this article is below:

About ACAM2000: it is manufactured by Emergent BioSolutions, headquartered in Gaithersburg, MD. The FDA approved ACAM2000 for use for the prevention of Smallpox in August, 2007. It contains vaccinia, a live virus ingredient used in modern Smallpox vaccines. The vaccinia used in ACAM2000 is a replicating version. The vaccine is cultured in a mixture of African Green Monkey kidney cells (sound familiar? — as in, perhaps, SV40 African Green Monkey cancer promoter gene splice that was found in the Pfizer-BioNTech modRNA COVID-19 “vaccine” by Dr. Kevin McKernan?). ACAM2000 was originally only intended for use to prevent Smallpox — until its use was “suddenly expanded” on 29 August 2024 by the FDA to include prevention of Mpox (more on that later in the post.) Since then, articles such as this one have appeared (https://childrenshealthdefense.org/defender/fda-acam2000-mpox-vaccine-warning-death-unvaccinated/, 17 September 2024, by Suzanne Burdick, Ph.D.; and, social media has been posting items like this one: https://x.com/toastontheside/status/1835921932841062412. This tweet references the FDA-issued handout for patients and/or caregivers regarding ACAM2000. The FDA handout is found here: www.fda.gov/media/75800/download. FDA handout documents for patients and/or caregivers are likely to have, in Yours Truly’s opinion, “sanitized” information and “pablum-like” assurances regarding the “safety and efficacy” of the drug or injectable. The FDA handout for ACAM2000, however, is different: when one reads the handout, one gets a distinct impression that this “vaccine” is highly dangerous. Below is a screenshot portion of the FDA patient/caregiver handout for ACAM2000:

Note that there is NO MENTION of the other FDA-approved Mpox vaccine, JYNNEOS, which is arguably “safer” for the patient (see further down in the presentation regarding JYNNEOS.)

The Fact Sheet for Healthcare Providers for ACAM2000 is here: www.fda.gov/media/75792/download. The document gives a much more comprehensive picture of the dangers of this “vaccine.” Yours Truly will highlight a few of the items in this document which show how dangerous and deadly this vaccine is, beginning with two images from page 1 of the Fact Sheet: the Black Box Warning; and, the Warnings and Precautions:

Remember, this dangerous and deadly “vaccine” is now approved for persons “at risk for Mpox”, in addition to persons at risk for Smallpox (this disease was eradicated in 1980.)

And, from Section 6 Adverse Reactions portion of the Fact Sheet for ACAM2000:

Continuing with Section 11 Description from the Fact Sheet for ACAM2000:

And, from Section 17 Patient Counseling Information of the Fact Sheet for ACAM2000, two portions:

Note several items from the above screenshots: One, that the “vaccine” must be given to the recipient via 15 separate jabs with a bifurcated needle; Two, there are MULTIPLE adverse reactions potential for persons taking this “vaccine”; Three, that persons who contract a Smallpox infection from a person “vaccinated” with ACAM2000 can die of the infection they contract; Four, that the ACAM2000-“vaccinated” person must stay away from pregnant women, household members, persons with eczema, etc., for a period of time after “vaccination”; among many other issues.

Yours Truly will again recall to the reader’s mind that ACAM2000 is now FDA-approved for PREVENTIVE USE among persons who are at risk for Mpox. From what Yours Truly has read about it, Mpox is, for all intents and purposes, likely to be a LESS-DANGEROUS form of Orthopoxvirus, compared to another form of the same Genus, variola (Smallpox virus.) [HOWEVER, see the presentation answering Question Two, further below in the post.] There is a vaccine that was previously FDA-APPROVED for the prevention of Mpox — JYNNEOS, manufactured by Bavarian-Nordic. This vaccine also uses the vaccinia virus as the foundation; but, JYNNEOS is cultured in a mixture of chicken embryo cells; and, although it also has live vaccinia, it is a NON-replicating version. JYNNEOS was also originally FDA-approved for the prevention of Smallpox. In Yours Truly’s opinion, even though JYNNEOS does indeed have potential for serious adverse reactions (for example, cardiac issues), this vaccine appears to be much less dangerous and deadly compared to ACAM2000. The FDA Fact Sheet for Healthcare Providers for JYNNEOS is here: www.fda.gov/131078/download.

Two questions arise immediately: First, what is about ACAM2000 that makes it so dangerous?; and, Second, why did the FDA suddenly approve the use of ACAM2000 for the prevention of Mpox in August 2024?

As to the first question: ACAM2000 is the “descendant Smallpox vaccine” from the older Dryvax Smallpox vaccine, which was manufactured by Wyeth. ACAM2000 replaced Dryvax in August 2007, after FDA approval. The Package Insert (archived version) for Dryvax is here: https://biotech.law.lsu.edu/blaw/bt/smallpox/dryvax_label.htm. Below are two screenshots from the Package Insert for Dryvax:

Note that the inoculation process for Dryvax consisted of 2 or 3 punctures for the initial (primary) vaccination; and that 15 punctures were used for revaccination. However, ACAM2000 requires 15 punctures for the initial vaccination. Why 15 punctures for the initial vaccination? It would appear, in Yours Truly’s opinion, that requiring 15 punctures for the initial vaccination with ACAM2000 exposes the patient to more of the ingredients of the vaccine (think the Moderna COVID-19 modRNA “vaccines” all having more than 3 times the “mcg payload” of lab-enhanced SARS-CoV-2 spike protein PER INJECTION, as compared to the “mcg payload” of the Pfizer-BioNTech modRNA COVID-19 “vaccines.” [Which is NOT to say that the Pfizer-BioNTech modRNA “vaccines” are somehow “safer” than those of Moderna. THEY ARE NOT.])

Yours Truly turns to section 8.1 of the FDA Fact Sheet for Healthcare Providers for ACAM2000 (link above.) This “vaccine” is particularly dangerous to pregnant women, to women who wish to become pregnant, and to a fetus carried by a pregnant woman (whether or not she is “vaccinated” with ACAM2000, since persons “vaccinated” with this product will “shed” ingredients [from the forming / formed pustule, or the scab from the pustule, etc.], onto other persons who come into contact with the “vaccinated” person.) Below is section 8.1:

It would also appear that there is inherent danger due to the fact that ACAM2000 uses a live, replicating vaccinia (another Orthopoxvirus that is “weaker” than variola [the Smallpox virus], and which is used to make modern-day Smallpox / Mpox vaccines), as compared to the live, NON-replicating vaccinia that is used the JYNNEOS Smallpox / Mpox vaccine. Once inoculated (vaccinated) with ACAM2000, the vaccinia produces a kind of “mini-infection” in the patient, affecting the area around the inoculation site, along with the lymph nodes in the same area. Vaccinia may also appear in the blood of the patient. There is also the issue of “self-inoculation” by the ACAM2000-“vaccinated” patient (from scratching or “picking at” the scab that forms after the “mini-infection” pustule forms on the skin, and also when this pustule begins to clear); and for other reasons — the FDA Fact Sheet section 17 Patient Counseling Information for ACAM2000 discusses this. In addition, there is the varying amount of vaccinia concentration that is produced in the patient after ACAM2000 inoculation; see below from section 11 Description of the FDA Fact Sheet for Healthcare Providers:

In other words, there are many areas about the ingredients and mechanisms of ACAM2000 that raise the risk of complications, including death, for the patient who takes this “vaccine”, for pregnant women and their fetuses, for women who wish to become pregnant, for persons who are immunocompromised, and for persons who are NOT “vaccinated” with ACAM2000, during the multiple “danger zone” weeks after ACAM2000 inoculation.

Turning to the second question, concerning the FDA approval in August 2024 for ACAM2000 to be used as an Mpox “vaccine”: this situation is complex. It involves Big Pharma, the WHO, and, what to Yours Truly “smells like” Gain-of-Function research, among other items.

Yours Truly will begin with Emergent BioSolutions, the company that produces ACAM2000. Emergent BioSolutions, a “global enterprise” with headquarters in Gaithersburg, MD, was established in 1998. Its first project was to partner with the United States Defense Department to supply the Anthrax vaccine that was administered to members of the military (www.emergentbiosolutions.com/about-us/.) The current CEO of the company is Joseph C. Papa. Mr. Papa’s most-recent position was CEO of Bausch + Lomb, another large Big Pharma company. Mr. Papa, apparently, is a “mover and shaker” in the pharmaceutical industry. However, it is also apparent that Baush + Lomb was in financial trouble when he left it to become CEO of Emergent BioSolutions. In fact, Bausch + Lomb is “exploring” selling off some of its pharmaceutical assets, due to “significant debt load” (https://finance.yahoo.com/news/bausch-lomb-explores-sale-amid-112230409.html.) Perhaps, the company’s Post-IPO debt funding was not enough: www.crunchbase.com/organization/bausch-lomb/company_financials; scroll down to “Investors.” Mr. Papa has Bachelor’s and Doctorate degrees in Pharmacy; his career includes working with many Big Pharma companies (Novartis, Cardinal Health, and Watson Pharmaceuticals, among others.) Please see his entry in Wikipedia; and, here: https://waterstreet.com/people/papa-joseph. Water Street (Water Street Healthcare Partners) is an investment company that has a portfolio worth approximately $6Billion spread across healthcare services companies, medical diagnostics companies, and pharmaceutical/life sciences companies (https://waterstreet.com/companies.)

Mr. Papa was hired on 21 February 2024 by Emergent BioSolutions to facilitate the financial turnaround of the company. Below is a screenshot of the company’s financials from September 2023 to September 2024, via Crunchbase. It appears that Mr. Papa, a “mover and shaker” in the Big Pharma world, is working hard:

Also, via Crunchbase, a snapshot of Emergent BioSolution’s funders:

Which leads to this: https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-acam2000r-smallpox-and-mpox-vaccinia, “Emergent BioSolutions’ ACAM2000R (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa and Other Regions”, 29 August 2024. The announcement follows this, from the WHO: www.who.int/news-room/questions-and-answers/item/mpox, 17 August 2024. A screenshot of a portion of article is below:

Which also follows the WHO declaration of an “Mpox Public Health Emergency” in Africa: https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-responds-mpox-public-health-emergency, 19 August 2024.

It appears that now, Mpox is being “re-classified” as another, although serious, sexually-transmitted disease that can infect any sexually-active person; and, that Mpox has apparently “made the leap” from monkeys to other animals (rodents and even to domesticated dogs), and to between animals and humans. This leads to another aspect of the situation: Yours Truly’s suspicion that there have been / are ongoing, Gain-of-Function experiments on Mpox.

Here is the “fast and dirty” summary on Gain-of-Function experiments with Mpox:

One: Up until 22 August 2024, the FDA had only ONE approved “vaccine” for Mpox: JYNNEOS. However, on that same day, the FDA conducted a “review” of the BLA Application (Biologics License Application) for ACAM2000 to have approval as a “vaccine” for Mpox. This application was approved on 29 August 2024 (www.fda.gov/news-events/press-announcements/fda-roundup-august-30-2024.) Please see: www.fda.gov/media/181552/download for the BLA review. The FDA reviewers, apparently, had some “reservations” about ACAM2000 — see the screenshot below:

Despite the multiple reviewer comments regarding the BLA for ACAM2000, the FDA approved it anyway for Mpox “prevention.” In fact, look at THIS, from section 11.2 of the ACAM2000 BLA document, below:

Two, the Gain-of-Function issue regarding Mpox: First, the CDC connection:

The CDC has a”working relationship” with countries all over the world, including African countries: www.cdc.gov/global-health/about/index.html. The NIH has an entire department, the Fogarty International Center, part of the agency’s “global outreach.” Here is the agency’s link to the “Sub-Saharan African Region”: www.fic.nih.gov/WorldRegions/Pages/SubSaharanAfrica.aspx.

The “Fauci connection” related to his article regarding the role of the NIAID “…in preparing for an expanded “biodefense” role”, April 2022: www.ojp.gov/ncjrs/virtual-library/abstracts/expanded-biodefense-role-national-institutes-health. The NCJ Number is 194395. Below is the Abstract:

The CDC has an updated report on the incidence of Clade II infections of Mpox, an outbreak that originated in Central Africa (more on Clade II of Mpox further down in today’s post): www.cdc.gov/, “Clade II Mpox Outbreak Originating in Central Africa”, 13 September 2024. Per this article, there are no Clade I Mpox infections in the United States at this time; however, there are 2466 reported cases of Clade II Mpox infections, with 7 deaths. There are also, per the CDC report, cases of Clade II of Mpox literally all over the world at this time.

Here is an example of Gain-of-Function experiments with the Clade II of Mpox. This paper is about a study conducted at Kansas State University in which pigs were exposed to the Clade II of Mpox to see if they would get sick, and then take various blood and biological samples and test them. Sure enough, the pigs contracted Mpox. Please see: www.ncbi.nlm.nih.gov/pmc/articles/PMC11168330/, “Experimental inoculation of pigs with monkeypox virus results in productive infection and transmission to sentinels”, Emily Mantlo, et al., 7 May 2024. “Sentinels” were the pigs who were not injected with the Clade II Mpox, but were put in the same cages as those pigs who were. The “sentinel” pigs also came down with Mpox (in other words, animal-to-animal transmission of the virus.) Below are the Ethics Statement and the Funding Statement for this study:

Note that the study was conducted in BSL-3 labs at KSU; that tissue-processing was performed at CDC BSL-2 facilities; and, that, apparently, college students were working in the BSL-3 labs in the study. This indicates that Gain-of-Function experiments with the Clade II of Mpox were being performed; that lower-level biosafety labs were used; and, that college students were involved (how much close supervision was provided by KSU?)

Yours Truly now turns to the alarms being sounded regarding this Gain-of-Function research on Mpox, beginning here: www.science.org/content/article/house-republicans-fault-nih-for-evasive-answers-on-risky-monkeypox-virus-study, 11 June 2024. This is followed by: https://usrtk.org/risky-research/fauci-institute-hid-mpox-gain-of-function-plans/, 11 June 2024, by Emily Kopp. A screenshot from the USTRK article is below:

The link to the Congressional report is here.

So, Gain-of-Function experiments are being performed using the Mpox virus; experiments funded by the NIH. A very dangerous, deadly Smallpox “vaccine”, ACAM2000, was suddenly FDA-approved for the “prevention” of Mpox. The “definition” of who is “at risk” for an Mpox infection has been “expanded” to include all persons who are sexually active. The Clade II of Mpox (the one that is the subject of the Gain-of-Function experiments) is now infecting people all over the planet, including in the United States. And more. Cui bono? How many of the general public will line up for an injection of ACAM2000 because the CDC / FDA / AMA / Establishment Medicine, will issue a warning due to “increasing numbers of infections being reported of Mpox?” How many healthcare professionals will be “mandated” into taking ACAM2000 “to protect themselves and the patients they care for?” (Again, JYNNEOS was already approved for Mpox “vaccination”, and it is ** potentially ** a “safer” alternative “vaccine.”) How many more Gain-of-Function experiments will be conducted, not in facilities like the Wuhan Institute of Virology or the Baric Lab at UNC Chapel Hill — but at places like the BSL-3 Ag Lab at Kansas State University (a facility where, arguably, one would expect research on, say, equine viruses, not Clade II Mpox experiments on pigs)? How much more Gain-of-Function experimentation will be hidden and/or “obscured” from public knowledge, let alone from Congress?

Peace, Good Energy, Respect: PAVACA

Dear KMAG Health Friday Open Thread: The COVID-19 “Vaccines” Induce ME/CFS (Chronic Fatigue Syndrome): A Response to Steve Kirsch

The above vintage image of a tired woman is courtesy of QuoteGram, via Google Images.

Today’s Health Friday post, as it relates to COVID-19 and the COVID-19 “vaccines”, is dedicated to the memory of Yours Truly’s cousin Bill, who died “suddenly and unexpectedly” in September 2023. Health Friday is a series of offerings related to Big Pharma, vaccines, general health, and associated topics. However, the discussion is not limited to what is presented today: It is an Open Thread.

To begin, there are Important Wolf Moon Notifications, with a couple of extra items:

Free speech is practiced here: “Use it or lose it.”

The following are alternate Q Tree sites for certain circumstances:

The U Tree is for “argue it out” interactions.

The Rescue Thread at the U Tree: click on the Featured article there.

The Third site, in case the above two are not accessible.

Civil discussion is practiced here. The excellent and timely Rules of our late. good Wheatie prevail:

One: No food fights.

Two: No running with scissors.

Three: If you bring snacks, bring enough for everyone.

Please follow the Added Guidelines as expressed. Please do not give the modern-day version of Cato the Elder the opportunity to show “enmity” to the board.

The extra items:

What Yours Truly presents in this series, as in her previous blog posts for this board, is not medical advice — they are opinions and hypotheses based on her over 4 1/2 years (and continuing) of reading about, researching about, and writing about, “all things COVID”, Big Pharma, and other health topics. Readers are encouraged to consult a healthcare practitioner regarding health concerns or conditions.

Note: If any reader of today’s post is also a subscriber to Mr. Kirsch’s Substack (https://kirschsubstack.com/), it would be much appreciated if the link to this post could be sent to him. Thank you.

Dear Mr. Steve Kirsch:

Greetings. The writer of this post is a regular reader of your Substack site. Many thanks for all your efforts in exposing the truth about the COVID-19 “vaccines.” This is a response to your blog post of 30 August 2024, The COVID shots are fueling the rise of ME/CFS cases. While it is true that ME/CFS can present symptoms that are similar to that of “Long COVID”, I suspect that there may well be other items in play. To start, I am including an image of the VAERS chart that is in your blog post:

The incidence reports of CFS (ME/CFS) after taking COVID-19 “vaccines” far outstrips all of the other vaccines listed.

The Statement from the Paul-Ehrlich-Institut on “Post-Vac Syndrome” after COVID-19 Vaccination, regarding the PEI study mentioned in your post: www.pei.de/EN/newsroom/positions/covid-19-vaccines/statement-postvac.html, of 19 May 2023, has this (a portion of the screenshot):

I note that the Paul-Ehrlich-Institut is an agency of the German federal government. It is the equivalent to the FDA in the United States.

ME/CFS (Myalgic Encephalomyelitis / Chronic Fatigue Syndrome, also called Post Viral Fatigue Syndrome), is a medical condition that is difficult to diagnose and to treat: see Myalgic encephalomyelitis/chronic fatigue syndrome, per Wikipedia. For years, the condition has eluded efforts to isolate and identify elements that cause it; until fairly recently, only the presenting symptoms were recognized and treated: www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/symptoms-causes/syc-20360490; and, www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/diagnosis-treatment/drc-20360510. However, there have been recent discoveries that relate to one potential element in ME/CFS: mitochondrial dysfunction that interferes with a protein called WASF3. It appears that high levels of WASF3 can create what may be called a “cellular energy deficit”, which, in turn, can create fatigue. One example of the research on this is here: www.pnas.org/doi/10.1073/pnas.2302738120, WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome, Paul H. Hwang, et al., 14 August 2023. WASF3 is a component of the Human Chromosome 13: https://en.wikipedia.org/wiki/Category:Genes_on_human_chromosome_13, click on “Next Page” at the bottom of the A-U alphabetical list of proteins on the article.

ME/CFS conditions existed well before either the SARS-CoV-2 (COVID-19) virus itself, or the COVID-19 “vaccines” — per Wikipedia, Dr. Melvin Ramsay “published the first diagnostic criteria for ME” (Myalgic encephalomyelitis) in 1986. (Wikipedia search “history of ME/CFS”) However, cases of ME/CFS began to present in otherwise healthy people after they contracted a case of COVID-19 early on in the COVID-19 pandemic (before the COVID-19 “vaccines” were in use.) One such case is summarized here, in the Yale Medicine blog: Long COVID, ME/CFS and the Importance of Studying Infection-Associated Illnesses, 13 May 2024, by Osman Moneer. Below is a screenshot from the article:

Note: “Dr. Deborah F.” is not her real name.

There also may be a link between ME/CFS, Long COVID, and negative emotional-psychological outcomes: Infections, ME/CFS, Long COVID and Psychosis: Is There a Link?, 16 July 2023, by Cort Johnson. A screenshot from part of The Gist section of the article is below:

This opens up the question, What is in the COVID-19 virus itself, and therefore in the COVID-19 “vaccines”, that can induce ME/CFS (Post-viral Fatigue)? Yours Truly turns to the report that Pfizer-BioNTech gave to the FDA on 30 April 2021, regarding post-authorization Adverse Event Reports submitted to the company in people who took the first injection of the modRNA COVID-19 “vaccine” BNT162b2, between 12 December 2020 (the date on which the FDA granted the initial authorization for BNT162b2 to be used in the United States) and 28 February 2021. The report is here, via FOIA release: www.phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf. Page 30 of this report is the APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST. This is a nine-page listing of over 1,200 serious Adverse Events that occurred in people who were “vaccinated” with BNT162b2 during the report period. Page one of this list has two types of damage to the mitochondria reported: “Alanine aminotransferase increased”; and, “Antimitochondrial antibody positive”. Page three lists “Chronic fatigue syndrome.” Page five lists “Immune-mediated encephalitis” and “Immune-mediated encephalopathy.” Page seven lists “Post viral fatigue syndrome.” In other words, at least six types of mitochondrial, neurological. or “body-wide” issues that are induced by modRNA COVID-19 “vaccines”, which can present in various forms, including CFS or ME/CFS.

There is also a link between the Epstein-Barr Virus (EBV) and the COVID-19 “vaccines.” EBV can be an “adjunct” presenting condition related to ME/CFS. Yours Truly found one paper, by Japanese researchers, on EBV presenting after “vaccination” with BNT162b2 (the Pfizer-BioNTech COVID-19 “vaccine”, [Epstein-Barr virus-associated lymphoproliferative disorders after BNT162b2 mRNA COVID-19 vaccination], from 2023. Only the Abstract is available in English. It is below:

It is now known that the COVID-19 “vaccines” (actually, gene therapy injections) do the following to the “vaccinated” person’s body:

Cross the Blood-Brain barrier (BBB); interfere with / damage / destroy mitochondrial elements and mechanisms; can induce negative effects / interfere with neurological elements and mechanisms; can induce onset of psychological issues, including psychosis; interfere with / damage or destroy, elements and mechanisms of the natural immune system (citations below.) These negative effects, in Yours Truly’s opinion, all have a bearing on the causation and presentation of COVID-19 “vaccine”-induced or aggravated ME/CFS. In order for these to occur, again in Yours Truly’s opinion, certain specific elements had to have been “inserted” into the lab-created SARS-CoV-2 (COVID-19) virus itself (and, by extension, into the lab-enhanced COVID-19 “vaccines”) to induce these types of damage. Perhaps it was a specific element that interacts with the WASF3 protein; perhaps it was a specific element that interacts with a component of the Epstein-Barr virus. Perhaps it was a specific element that interacts / interferes with other aspects of Human Chromosome 13. Perhaps it was all of these. I believe that ongoing research into the actual ingredients of the modRNA of the COVID-19 “vaccines” will eventually reveal the answers.

In addition, there are the following lipid nanoparticle (LNP) ingredients in the modRNA COVID-19 “vaccines”:

For the Pfizer-BioNTech “vaccines”: ALC-0159, ALC-0315, and PEG2000-DMG; for the Moderna “vaccines”: SM-102, ALC-0315, and PEG2000-DMG. All of these lipid nanoparticles are dangerous. All of them are to be used for research only, not for use in diagnosis or therapeutics for humans or for animals. All of them specifically “evade” the “vaccinated” person’s natural immune system’s “Are you a friend or a foe?” recognition and elimination mechanisms. They facilitate “access” of the ingredients and mechanisms of these modRNA COVID-19 “vaccines” to induce damage / destruction of the IgG3 “fight it off” immune system cells in the “vaccinated” person’s body; and, at the same time, to increase the amount of IgG4 “tolerate and never clear” immune system cells. This process is called the “Class Switch” done by the modRNA COVID-19 “vaccines.” (Citations below.)

In Summary: The COVID-19 virus itself can induce multiple negative medical effects on persons who contract an infection of the virus, including ME/CFS. The COVID-19 “vaccines”, which contain elements of the COVID-19 virus itself (in addition to other lab “enhancements” for these “vaccines”, such as the lipid nanoparticles), can therefore also induce multiple negative medical effects in persons who take these injectables, including ME/CFS. In addition, both the COVID-19 virus itself, and, by extension, the COVID-19 “vaccines”, can induce and/or aggravate negative psychological conditions. I believe that these “vaccines” need to be banned outright immediately and removed from the market across the world, until and unless such time they are completely reformulated and thoroughly tested (including testing by independent labs) for human safety, efficacy, toxicity, mutagenesis potential, and reproductive effects potential.

It is my opinion that: One, that all people, COVID-19 “vaccinated” or not, follow a personal program to acquire and maintain the highest degree of natural immune system health as possible; and, Two, that all people investigate any vaccine that is recommended (or “mandated”), then, to decide whether or not to take the injectable(s.)

Citations regarding the In Summary above, the lipid nanoparticles, and the “Class Switch”:

Lipid nanoparticles: ALC-0159: https://cdn.caymanchem.com/cdn/msds/34336m.pdf; ALC-0315: https://cdn.caymanchem.com/cdn/msds/34337m.pdf; SM-102: https://cdn.caymanchem.com/cdn/msds/33474m.pdf; PEG2000-DMG: https://cdn.caymanchem.com/cdn/msds/33945m.pdf. Please see Application of the Substance / the mixture on page one of these Safety Sheets.

Crossing the Blood-Brain Barrier: Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis, Ioannis Trougakis, et al., 21 April 2022.

Mitochondrial damage: SARS-CoV-2 and the spike protein in endotheliopathy, Luca Perico, et al., 12 June 2023; and, www.theqtree.com/2023/10/28/the-covid-19-virus-and-the-modrna-covid-19-vaccines-induce-accelerated-aging/.

Neurological side effects: A review of neurological side effects of COVID-19 vaccination, Roya Hosseini and Nayere Askari, 25 February 2023. And, COVID-19 “vaccine”-induced psychosis: First Episode Psychosis Following the COVID-19 Vaccination – A Case Series. Tonka Borovina, et al., 18 May 2022.

The IgG3 – IgG4 “Class Switch”: IgG4, CD4s and why the LNP/mRNA platform should be prohibited, Jessica Rose, PhD, 14 August 2023.

Thank you for your time, Mr. Kirsch. Sincerely, with Peace, Good Energy, and Respect: PAVACA

Dear KMAG 2024.08.30 Health Friday Open Thread: The American Board of Internal Medicine Dictates “Toe the Line, Or Else”

The above image is courtesy of Board and Batten.

This post is part of Health Friday, a series of offerings related to Big Pharma, vaccines, general health, and associated topics. However, the discussion will not be limited to what is presented today; it is an Open Thread.

To begin, there are Important Wolf Moon Notifications, with a couple of extra items:

Free Speech is practiced here. “Use it or lose it.”

The following are alternate Q Tree sites for certain circumstances:

The U Tree is for “argue it out” interactions: https://utree.com.blog

The “Rescue Thread” at the U Tree: https://utree.home.blog and click on the “Featured” article.

The “third site”, in case the above two are not accessible: https://theqtree579486807.wordpress.com/

Civil discussion is practiced here. The excellent and timely Rules of our late, good Wheatie prevail:

One: No food fights.

Two: No running with scissors.

Three: If you bring snacks, bring enough for everyone.

Please follow the added guidelines as expressed here: www.theqtree.com/2019/01/01/dear-maga-open-topic-20190101/. Please do not give the modern-day version of Cato the Elder the opportunity to show “enmity” to the board.

The extra items:

What Yours Truly presents in this series, as in her previous blog posts for this board, is not medical advice — they are based on her over 4 1/2 years (and continuing) of reading about, researching about, and writing about “all things COVID”, Big Pharma, and other health topics. Readers are encouraged to please consult a healthcare practitioner regarding health concerns or conditions.

Today’s post in the Health Friday series regards the ongoing efforts by what Yours Truly calls Establishment Medicine to minimize, marginalize, and/or outright punish those healthcare professionals (especially physicians) who speak the truth about the COVID-19 virus itself and the COVID-19 “vaccines.”

For purposes of the post today, Yours Truly begins here: ABIM: “Follow the consensus, not the science. Saving lives is not a priority.”, from The Burning Platform, a post by Steve Kirsch. This details the American Board of Internal Medicine revoking the certifications of Dr. Pierre Kory and Dr. Paul Marik. The Washington Post and other media outlets gloated over this, trumpeting that the “medical disinformation spread” by these physicians (such as, that Ivermectin and Hydroxychloroquine can prevent and cure COVID-19 infections; and, that the modRNA COVID-19 “vaccines” are dangerous) was finished. Yours Truly’s presentation focuses on the ABIM decision regarding Dr. Kory.

Dr. Pierre Kory is a co-founder of COVID-19 Critical Care (FLCCC): https://covid19criticalcare.com/. He has been, and is, since the beginning of the disaster of COVID-19 and the COVID-19 “vaccines”, a leading voice in exposing the truth of this situation, along with being a champion of using Ivermectin and Hydroxychloroquine to prevent a COVID-19 infection and to treat COVID-19 infected patients. Until this month, Dr. Kory held three board certifications from the American Board of Internal Medicine — until this happened: The American Board of Internal Medicine Revoked All 3 of My Board Certifications, 17 August 2024. This is a big deal. Here’s why: By this action, the American Board of Internal Medicine (ABIM) removed Dr. Kory’s ability to have hospital privileges; it removed his ability to hold an academic position; and, it removed his ability to work in a medical clinic or other facility where other physicians hold ABIM certifications. Dr. Kory can still practice medicine in a private clinic where there no ABIM physicians; or, he can work independently in a clinic that he himself establishes. Below are three screenshots from Dr. Kory’s article:

Note the above third screenshot. To remove the ability of physicians to “think out of the box” will be, in Yours Truly’s opinion, to implement “one-size-fits-all Establishment Medicine.” And this is not all — this approach will (if it hasn’t already) spill over into the CMS (Medicare / Medicaid) system, making it almost impossible for persons covered under this system to find physicians who want to “think out of the box.”

The history of medical board certification in the United States began in 1917. A brief history can be found here: www.ncbi.nim.nih.gov/pmc/articles/PMC2394686/, “Professionalism and Accountability: The Role of Specialty Board Certification”, by Christine K. Cassell, MD, and Eric S. Holmhoe, MD, 2008. There are multiple entities that grant board certifications to physicians. Two of them are: the American Board of Medical Specialties (ABMS) www.abms.org/, which grants certifications in 40 specialties and 89 “sub-specialties”; and, the American Board of Internal Medicine (ABIM) www.abim.org/, which grants certifications in 14 specialties. In essence, board certification, which was at one time was an “add-on” to a physician’s already-established reputation and expertise is now a necessity — there is hardly a hospital, or a medical school, or a group practice that will consider hiring a physician who does not have a board certification, or is not working toward one. And, with the advent of “get board certified or forget about being hired”, comes what Yours Truly will call “the potential tyranny” of the granting entity over the physician who is board certified. There is continuing education and exams to renew the certifications; all of these cost money. There is “oversight” on the physician who obtains board certification — for example, are there any complaints from patients? Does the physician “spread misinformation” about things like the COVID-19 “vaccines” and/or “unapproved treatments” for COVID-19 infection? The granting entity can “charge” a physician who has board certification with “spreading misinformation” and/or “treating a patient with unapproved drugs”; the physician has to “defend” themself before the granting board in order to keep or to renew their certification(s). The granting entity has the sole power to either renew or to revoke the physician’s certification(s).

An opposite point of view on board certification is expressed here: Is Board Certification Overrated?, by Robert Anthony, 2010 (copyright 2010 by UBM). Below is a portion of the article:

On the other hand, here a screenshot from the ABMS article, About ABMS Board Certification:

Which appears, in Yours Truly’s opinion, to imply that a physician who is not board certified is somehow “lacking” in skills and knowledge and, perhaps, does not “meet a higher standard.”

Perhaps the most damning statement by Dr. Kory regarding the ABIM revoking his board credentials is this one, from his blog article referred to above:

Dr. Kory published a blog article in reply to the ABIM action against him: My Retaliation Against the American Board of Internal Medicine, 20 August 2024. Below is a screenshot from this article:

Read the above again. The ABIM has removed Dr. Kory’s ability to see patients in a hospital. He can’t participate in insurance plans — which means that any patient he sees in his own clinic must pay for all services, tests, and so on, out of pocket. This may include charges that would normally be covered by Medicare / Medicaid. He will have to carry less medical malpractice insurance. All of these can potentially mean that patients who need his services but cannot pay cash for them, are also potentially shut out from his services. His article above needs to be read: in it, he “exposes the underbelly” of the ABIM.

Dr. Meryl Nass (https://merylnass.substack.com/) also had her board certification revoked by the ABIM. The organization did not even bother to tell her that this was done: https://merylnass.substack.com/p/kory-and-marik-were-just-stripped, “Kory and Marik were just stripped of their specialty board certifications. So was I, but the ABIM never even bothered to tell me”, 14 August 2024. Dr. Nass also, in another blog post, reveals what may one item behind what the ABIM is doing — the organization apparently wants to replace the physicians whose certifications were revoked with medical doctors from foreign countries: https://merylnass.substack.com/p/after-stripping-doctors-of-their, “After stripping doctors of their credentials and making it impossible to practice ethical medicine, the ABIM wants to bring in foreign medical doctors as replacements”, 24 August 2024. Below is a JPG of the ABIM’s statement, shared by Dr. Nass from another physician:

To add another aspect to the discussion, Yours Truly believes there ** may ** be some involvement of the AMA (American Medical Association) in the revoking of board certifications: AMA adopts new policy aimed at addressing public health disinformation, 13 June 2022. Below is a screenshot from the press release:

Note the penultimate point regarding “specialty boards.” In Yours Truly’s opinion, the AMA is one of the bastions of what may be called “Establishment Medicine” (the others being entities such as: the CDC; the FDA; the medical schools of Harvard University, Stanford University, Cornell University, etc.)

Let’s say that a board-certified physician, “fully vaccinated and boosted” who “followed the science”, after watching “vaccinated and boosted” patients, colleagues, perhaps even family members, begin to present with “the doctors are baffled” medical issues; or, perhaps, a cancer that was in remission that has returned. Let’s say that this physician starts to feel a little uneasy regarding the modRNA COVID-19 “vaccines” and does a little research — perhaps, by reading a blog or two written by someone like Dr. Kory; perhaps, by reading some published scientific literature regarding “first onset of psychosis after SARS-CoV-2 vaccination” (there are multiple papers discussing this that can be found online.) Let’s say that this physician comes to the realization that the modRNA COVID-19 “vaccines” are not “safe and effective”, but instead are the opposite. Let’s say this physician has board-certification renewal coming up in a few months. And, to top it off, let’s say that this physician has a family to provide for, a mortgage to pay, and medical school debt to pay off. What is this physician to do? — without jeopardizing the job, the board certification, perhaps even the License to Practice Medicine? It is Yours Truly’s opinion that this kind of situation is starting to “bubble under the surface” of more than one physician currently in practice. It is not an easy situation to be in.

Where does this situation leave the patient? If the physician who discovers that the modRNA COVID-19 “vaccines” (actually, gene therapy and modification injections [the DNA of the “vaccinated” person is changed by the ingredients and mechanisms of these “vaccines”]) are ineffective and dangerous, but doesn’t / can’t say a word to the patient to not take them — doesn’t this violate the oath of “First, Do No Harm” that the physician swore upon receiving the degree of Doctor of Medicine? If the physician who finds out, for example, that Paxlovid has a high “rebound infection” percentage, but doesn’t / can’t say a word to the patient to not take this combo-drug but substitute, say, Hydroxychloroquine, Zinc, and Vitamin D to combat a COVID infection — doesn’t this silence put the patient at risk? One in Five Experience Rebound COVID After Antiviral Drug, New Study Shows, 13 November 2023. The article regarding the DNA change made by the modRNA COVID-19 “vaccines” is here: https://doctors4covidethics.com/wp-content/uploads/2022/08/causality-article. “Vascular and organ damage induced by mRNA vaccines: irrefutable proof of causality”, by Michael Palmer, MD, and Sucharit Bhakdi, MD, 18 August 2022. Slide 14 of this article is a graphic showing how the DNA of the COVID-19 “vaccinated” person is changed by the Pfizer-BioNTech modRNA COVID-19 “vaccine.”

How did the ABIM, the ABMS, and the other privately-run board certification granting entities in the United States come to have such power over the practice of medicine and over the physicians who obtain board certification? (There are literally dozens of these boards: www.americanboardcosmeticsurgery.org/so-what-does-physician-board-certification-actually-mean/, 7 February 2019.) To Yours Truly, it appears that they possibly used a combination of influence, lobbying, personal connections with medical schools, and other “tactics.” The result may well be an “authority” that these certification boards created and arrogated to themselves, in the name of “ensuring quality delivery of healthcare by qualified physicians.” While this may have been a true and worthy aspiration previously, it seems it has “evolved” into “Follow these dictates, or else.”

And, from there, where does this potentially go? If a physician is stripped of board certification(s), that physician can still practice medicine — unless their state medical licensing board (perhaps with the involvement of the AMA, please see above in today’s post) decides to “charge” the physician with “spreading disinformation to the public” in “violation” of the diktats of Establishment Medicine. The physician now faces the possibility of losing the License to Practice Medicine. The case of Dr. Carrie Madej, DO, comes to mind. (Doctors of Osteopathy are medical doctors who have somewhat different training from MDs, but who are recognized and licensed to practice medicine and write prescriptions.) She was brought up on similar “charges” by the medical licensing board of Georgia. After a protracted fight, Dr. Madej ultimately decided to surrender her License to Practice Medicine in 2023. (Recall that Dr. Madej was one of the first to demonstrate that the modRNA COVID-19 “vaccines” contain substances that appeared to be strange.)

And, from there, where does the potential for innovation in medicine go? If physicians (especially board-certified physicians) have to, in effect, constantly “look over their shoulder” and “toe the line” to Establishment Medicine, doesn’t this affect the potential to come up with new theories and to investigate them? — such as in, using drugs in “off-label” circumstances to help patients? — such as in, using Hydroxychloroquine to prevent or treat COVID-19 infection, instead of injecting a patient with a modRNA COVID-19 “vaccine” that changes that patient’s DNA and can also lead to the appearance of myocarditis or even to the death of the patient? Instead of hospitalized COVID-19 infected patients being put on ventilators and given Remdesivir, a drug that can kill the patient instead of helping the patient? Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola, Victoria C. Yan and Florian L. Muller, 17 September 2021.

Yours Truly will say it is vitally important that all persons, COVID-19 “vaccinated” or not, to have and keep their natural immune system in the best condition possible; to become educated regarding any prescription medication that they take; and, to research any medical injectables that are recommended / required that they be given.

“For you shall know the truth, and the truth shall make you free.” John 8:32

Peace, Good Energy, Respect: PAVACA

Dear KMAG: 2024.08.23 Health Friday Open Thread: The modRNA COVID-19 “Vaccines” Induce IgG4-Related Disease

The above image of a physician performing a vaccination is courtesy of Google Images and The New York Times.

This post is the first of “Health Friday”, a new series of offerings related to Big Pharma, vaccines, general health, and related topics. It is an honor and privilege to contribute this series to the board. Since today’s post relates to COVID-19 and the COVID-19 “vaccines”, it is dedicated to the memory of Yours Truly’s cousin Bill, who “died suddenly and unexpectedly” in September 2023. However, the discussion will not be limited to what is presented today; it is an Open Thread.

To begin, there are Important Wolf Moon Notifications, with a couple of extra items:

Free Speech is practiced here. “Use it or lose it.”

The following are alternate Q Tree sites for certain circumstances:

The U Tree is for “argue it out” interactions: https://utree.home.blog

The “Rescue Thread” at the U Tree: https://utree.home.blog and click on the “Featured” article.

The “third site”, in case the above two are not accessible: https://theqtree579486807.wordpress.com/

Civil discussion is practiced here. The excellent and timely Rules of our late, good Wheatie prevail:

One: No food fights.

Two: No running with scissors.

Three: If you bring snacks, bring enough for everyone.

Please follow the added guidelines as expressed here: www.theqtree.com/2019/01/01/dear-maga-open-topic-20190101/. Please do not give the modern-day version of Cato the Elder the opportunity to show “enmity” to the board.

The extra items:

What Yours Truly writes in this series, as in her previous blog posts for this board, is not medical advice — they are opinions based on her over 4 1/2 years (and continuing) of reading about, researching about, and writing about “all things COVID”, Big Pharma, and other health topics. Readers are encouraged to please consult a healthcare practitioner regarding health concerns or conditions.

And now, to dive in. There is a lot to “unpack.”

The modRNA COVID-19 “vaccines” induce IgG4-related disease (IgG4-RD.) IgG4-related disease (IgG4-RD) is a term that covers multiple medical conditions, ranging from neurological to ocular to cardiovascular to respiratory to gastrointestinal to urogenital. Since it is a chronic inflammatory condition, there can be more than one location of an IgG4-RD associated ailment within the patient’s body. Please see: https://en.wikipedia.org/wiki/IgG4-related_disease, “IgG4-related disease”, which has a list of symptoms in reported cases of IgG4-RD, and a list of body area sites that can be affected by IgG4-RD. The first instance of what is now called IgG4-RD was discovered in 1892 by Johann von Mikulicz, who diagnosed an “inflammatory disease of the salivary glands” in a patient (this condition was later called Mikulicz’ disease.) In 2021, Hamano et al. found elevated IgG4 levels in patients with Autoimmune Pancreatitis (AIP.) Please see: https://ojrd.biomedicalcentral.com/articles/10.1186/s13023-014-0110-z, “IgG4-related disease: an orphan disease with many faces”, Herwig Pieringer, et al., 16 July 2014. It appears that an issue with obtaining a true diagnosis of an IgG4-related disease is that many of the presenting elements can “mimic” other conditions, such as cancer or non-Hodgkin’s lymphoma. In addition, IgG4-RD can simply not present symptoms at all, until the patient concludes that “something is going on here.” In terms of the presenting symptoms of an IgG4-RD disease, there are, among others: storiform fibrosis (“spindle-shaped” cells that can, with collagen fibers, form a “flowing arrangement”); and, eosinophilia (high elevation of a type of white blood cell [eosinophils] that supports the natural immune system.) Please see: https://academic.oup.com/mr/article/31/3/529/6300281, “The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD”, Hisamori Umehara, et al., 4 May 2021. (Note: the entire article is restricted access.) Below is a portion from “IgG4-Related Disease” from StatPearls – NCBI Bookshelf, an article by Sudheer Nambiar and Tony I. Oliver (www.ncbi.nlm.nih.gov/books/NBK499825):

There are some IgG4-RD conditions that may be genetically-based; one example is Autoimmune Pancreatitis (AIP.) Please see: https://pubmed.ncbi.nlm.nih.gov/31104539/, “Genetic analysis of IgG4-related disease”, Yuki Ishikawa and Chikashi Terao, 7 June 2020. (Note: again, the entire article is restricted-access.) On the other hand, another IgG4-RD condition, Autoimmune Lymphoproliferative Syndrome (ALPS) appears to strike children. In addition, IgG4-RD conditions can be “immune-mediated” (meaning, the body’s immune system response is either inappropriate or excessive); and/or “autoimmune” (meaning, the body’s immune system attacks healthy tissues in the body.)

Yours Truly will examine the presence of eosinophilia as an indicator of IgG4-RD. This is an important “marker.” And it ties into the modRNA COVID-19 “vaccines” — the COVID-19 “vaccinated” person’s natural immune system being damaged and/or destroyed by the ingredients and mechanisms of these “vaccines”; and, with repeated injections of these “vaccines” compounding this damage and/or destruction.

The first item is a blog article by Dr. Jessica Rose, PhD: https://jessicar.substack.com/p/igg4-related-disease-and-igg4-means, “IgG4-related disease (IgG4RD) means FIBROSIS and organ destruction”, 28 December 2022. It is now known that the modRNA COVID-19 “vaccines” induce a “class switch” in the COVID-19 “vaccinated” person’s natural immune system; this “class switch” is the damage and/or destruction of IgG3 immune system cells (these cells help to fight off infections and other enemies that “invade” the natural immune system), replacing IgG3 cells with increased numbers of IgG4 cells (these cells help to allow the body to “tolerate” assaults to the natural immune system.) Repeated injections of modRNA COVID-19 “vaccines” exacerbate this process: please see https://doi.org/10.1126/sciimmunol.ade2798, “Class switch toward non inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination”, Irrgang P, et al., 22 December 2022. Notice the title: “non inflammatory”, “spike-specific”, “IgG4”, and “repeated SARS CoV-2 mRNA vaccination.” IgG4-RD conditions can present as non-inflammatory (the patient doesn’t notice anything wrong for some period of time, see above in today’s post); however, the IgG4 levels in the patient are high upon examination. Below is a portion of the Introduction of the above paper. Note: Comirnaty was the non-United States version of the Pfizer-BioNTech modRNA COVID-19 “vaccine” BNT162b2. Comirnaty and BNT162b2 are the same product. Note 2: the 2023-2024 Comirnaty modRNA COVID-19 “vaccine” was given full FDA approval for use in the United States on 23 September 2023 for persons age 12 above: www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-us-fda-approval-2023-2024-covid; the version that the FDA authorized (the “2023-2024 Formula COVID-19 Vaccine” by the same company) was for persons age 6 months through 11 years of age (www.fda.gov/media/167211/download.)

Note that the IgG4 cell increase extended for months after the second injection of Comirnaty and was further increased after the third injection. This correlates to the original “two-injection Primary Series” plus the original “booster shot” of Comirnaty that millions of persons took between December 2020 and early 2022. This would also include, since the formulations were the same, of the “Primary Series” and the original “booster shot” of BNT162b2 that were taken by millions of persons in the United States from December 2020, until Comirnaty was given full FDA approval in the United States on 8 July 2022 for persons age 12 and older (at which point, BNT162b2 was “replaced” by Comirnaty except for use in persons age 6 months to 11 years; the FDA authorized the “Pfizer-BioNTech COVID-19 Vaccine” for this age group.) This “product name situation” may seem a little confusing: at bottom, it had to with removal of liability for the “vaccine” manufacturer. This will be discussed at a later date.) Note also that “VOC” means Variants of Concern (in other words, the Delta, the Omicron, the XBB.1.5 variants of the SARS-CoV-2 [COVID-19] virus, and so on.)

The second item is here: www.phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf, 5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021, given by Pfizer-BioNTech to the FDA on 30 April 2021. This report covers Adverse Event Reports that were submitted to the company between 11 December 2020 (the date on which the FDA in the United States granted the initial Emergency Use Authorization (EUA) for BNT162b2 to be used in the United States, 21 December 2020 (the date on which the EMA (European Medicines Agency) granted its initial EUA for BNT162b2 to be used in Europe / Scandinavia; and, 28 February 2021. The APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST, which begins on Page 30 of this report, lists over 1,200 different types of medical adverse events that were reported to Pfizer-BioNTech from the worldwide EUA start dates above. On Page 3 and Page 4 of the APPENDIX 1. (Page 32 and Page 33 of the report), there are the following Adverse Events of Special Interest listed: Eosinopenia; Eosinophilic fasciitis; Eosinophilic granulomatosis with polyangiitis; Eosinophilic oesophagitis. On Page 5 of the APPENDIX 1. (Page 34) of the report, there is listed: Immunoglobulin G4 related disease. On Page 8 of the APPENDIX 1. (Page 37 of the report) there is listed: Sjogren’s syndrome (another type of IgG4-RD.) These are a few of the IgG4-RD types of reports that are listed in the APPENDIX 1. section. Thus, the FDA knew, on 30 April 2021, that BNT162b2 “vaccination” induces IgG4-related disease conditions. Yet, the FDA did nothing to stop the continuing rollout of BNT162b2.

A third item is here: https://mole.substack.com/cp/147758416, a 15 August 2024 cross-post from Lioness of Judah Ministry, “German Study Links Covid Shots to Surge in VITAL ORGAN DAMAGE among Children”. The study found that there was a large increase of organ damage induced by BNT162b2 in children in Germany ages 5 to 11 years old. The study is here: https://journals.lww.com/pidj/fulltext/9900/delayed_induction_of_noninflammatory_sars_cov_2.959.aspx, “Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children”. Kobbe, Robin MD, et al., 30 July 2024. The IgG4 antibodies were detected after the second dose of BNT162b2 (in other words, after the “Primary Series” of two BNT162b2 injections was completed.)

And, a fourth item is here, related to COVID-19, the COVID-19 “vaccines” and autoimmune conditions: https://wmcresearch.substack.com/p/long-covid-is-an-autoimmune-disease, “Long COVID is an Autoimmune Disease: Injecting Mice with IgG from Long COVID Patients Induces Symptomology”, by Walter M Chesnut, 4 June 2024. Mr. Chesnut has long posited that the spike protein of the COVID-19 virus itself contains elements that attack the natural immune system of the body of a person infected with this virus; and that the COVID-19 virus itself can induce what is now called “Long COVID.” Yours Truly will add the opinion that the difference between “Long COVID” in a person who is “unvaccinated” against COVID-19, and “Long COVID” in a COVID-19 “vaccinated” person, is this: the natural immune system of the “unvaccinated” person still has the potential to not only fight off a COVID-19 infection, but also to mitigate or eliminate the chance that “Long COVID” may result from the infection; whereas, the natural immune system of the COVID-19 “vaccinated” person has been damaged (or worse), resulting in a much larger potential for “Long COVID” (both in presentation and in duration.)

Yours Truly believes that the COVID-19 virus itself, and the ingredients and mechanisms of the modRNA COVID-19 “vaccines” (one of these ingredients being a “lab-modified” form of the RNA of said virus), both attack the natural immune system of the body. The COVID-19 “vaccines” have been shown to damage and/or destroy the IgG3 cells of the body’s natural immune system (these cells help to fight off viruses, etc.), replacing these with increased amounts of IgG4 cells (“toleration facilitator” cells.) In Yours Truly’s opinion, one of the important details here is the targeting of HLA cells (human leukocyte antigen cells, a type of white blood cells) by the COVID-19 virus itself, and, by extension, the COVID-19 “vaccines.”

In the book Biochemistry, HLA Antigens by Helen Nordquist and Radia T. Jamil, www.ncbi.nlm.nih.gov/books/NBK546662/, there is the following:

And, from this paper: www.ncbi.nlm.nih.gov/pmc/articles/PMC10864075, “HLA-DRB1 Is Associated with Therapeutic Responsiveness in IgG4-related disease”, Motohisa Yamamoto, et al., 23 May 2024:

Note that one of the most-recommended and used treatments for IgG4-RD conditions is glucocorticoids (steroids); and that cessation of treatment likely results in relapse of the condition. But, long-term use of glucocorticoids have risks, including high blood pressure and Cushing’s Disease. Please see: www.webmd.com/multiple-sclerosis/what-are-glucocorticoids.

Yours Truly will posit that the lab-created SARS-CoV-2 (COVID-19) virus itself, with the lab enhancements made to the mRNA of this virus to create the modRNA of the COVID-19 “vaccines” (such as the SV40 African Green Monkey cancer promoter gene piece in BNT162b2), plus the addition of dangerous lipid nanoparticles (ALC-0159 and ALC-0315 in BNT162b2 and its “descendant” COVID-19 “vaccines”; and, SM-102 in the Moderna mRNA-1273 modRNA COVID-19 “vaccines” and its “descendant” COVID-19 “vaccines”) and other ingredients in these “vaccines” — have been, and continue to be, designed to wreak as much havoc and damage on the human race as possible. This havoc and damage includes that done to the body’s natural immune system, its elements, mechanisms, and responses. Recall that the “descendant” modRNA COVID-19 “vaccines” use the original (lab-enhanced) SARS-COV-2 (COVID-19) virus modRNA that was present in the earlier versions of these “vaccines”, but in smaller amounts. Therefore, in one’s opinion, the potential exists for immune system damage in persons who take these “descendant” modRNA COVID-19 “vaccines.”

Until fairly recently, it was not known HOW, or the DETAILS behind WHY, the COVID-19 virus itself and the COVID-19 “vaccines” have such potential for havoc and damage — all that was beginning to present were, and are, the ADVERSE EFFECTS of the virus and especially of the “vaccines”: turbo-cancers; miscarriages; Bell’s Palsy; deaths; the Adverse Events of Special Interest listings of negative effects induced by BNT162b2 in the APPENDIX 1. cited above. It is now starting to become more clear as to what SPECIFIC elements likely used in the creation of both the SARS-CoV-2 virus itself, and in the development of the modRNA COVID-19 “vaccines.” Yours Truly will posit that one of these SPECIFIC elements is something that attacks and compromises at least one important component of the human body’s immune system: the antigen site of the human leukocyte protein DRB1 (HLA-DRB1.) It took time, effort, and large amounts of funding to investigate these SPECIFIC elements; to experiment with them to ascertain the damage that could be caused; then, to “insert” these elements into the SARS-CoV-2 virus itself, and, by extension, into the modRNA COVID-19 “vaccines.” And, as the passage of time obscures or obliterates “fingerprints” of the damage done by the COVID-19 “vaccines” in the “vaccinated” individual, the involvement of these “vaccines” may well become harder and harder to trace (even though the damage is continuing in the “vaccinated” person, since one of the mechanisms of said “vaccines” is to change the DNA of the person who takes them.) Below is Slide 14 from the Palmer, MD and Sucharit, MD, article regarding what the COVID-19 “vaccines” do to the “vaccinated” person’s body. Slide 14 shows how the Pfizer-BioNTech modRNA COVID-19 “vaccine” BNT162b2 changes the DNA of the “vaccinated” person:

The article is found here: https://doctors4covidethics.org/wp-content/uploads/2022/08/causality-article.pdf, “Vascular and organ damage induced by mRNA vaccines: irrefutable proof of causality”, by Michael Palmer, MD and Sucharit Bhakdi, MD, 18 August 2022.

Yours Truly will emphasize that it is of the utmost importance that all persons, COVID-19 “vaccinated” or not, have and maintain the highest degree possible of natural immune system health. A healthy diet is one of many ways to support and maintain a healthy natural immune system. Here is an article on this topic: www.medicalnewstoday.com/articles/322412, “The best foods for boosting your immune system”, by Lana Burgess, 10 July 2018. Among other ways to help the natural immune system are lifestyle changes, regular exercise, taking supplements, and addressing stress, as discussed here: www.healthline.com/nutrition/how-to-boost-immune-health, “9 Ways to Boost Your Body’s Natural Defenses”, by SaVanna Shoemaker, RDN, 1 April 2020. Yours Truly will add the opinion that avoiding unnecessary antibiotics and “certain injectables” are additional items to consider.

Peace, Good Energy, Respect: PAVACA

The HHS Gave the “Go-Ahead” to Use an H5N1″Vaccine”— But the AMA Just Issued New CPT Codes for an H5N8 “Vaccine”

The above image is of mass vaccination against smallpox in Paris in 1905. (Courtesy, Getty Images.)

Today’s post will trace what ** may be ** a “sleight-of-hand” that started out with Xavier Becerra, the Secretary of the United States government Department of Health and Human Services, giving the “Go-Ahead” for the use of the H5N1 Avian Influenza “vaccine”, AUDENZ, in anticipation of a potential “bird flu pandemic” in the United States; but, which since has been “transformed” into the American Medical Association just issuing new CPT codes for an Avian Influenza “vaccine” for a different strain, called H5N8. Meanwhile, the CDC / FDA / United States government, are all sending out warnings related to the H5N1 strain. Stay with Yours Truly, it gets even better — “Mais, mon Dieu!” — the twists and turns! This post is a kind of “snapshot” of the situation — it is an evolving issue.

For purposes of today’s post, the trail begins here: www.ernst.senate.gov/imo/media/doc/fowl_play_squeal.pdf, the letter that Sen. Jodi Ernst (R-Iowa) sent to USDA Secretary Tom Vilsack on 14 February 2024. In this letter, Sen. Ernst demands answers regarding United States government funding of what appears to be Gain-of-Function research experiments on Avian Influenza viruses; which experiments involve a scientist linked to the Chinese Communist Party. Yours Truly can find to date, no response from Sec. Vilsack to Sen. Ernst. A screenshot of Page 1 of her letter is below:

Yours Truly now turns to this: www.aha.org/news/headline/2024-07-23-hhs-broadens-emergency-declaration-facilitate-response-bird-flu-other-viruses-pandemic-potential, “HHS broadens emergency declaration to facilitate response to bird flu, other viruses with pandemic potential”, dated 23 July 2024, which “expanded” the 2013 amendment to the Federal Food, Drugs, and Cosmetics Act to now include “other viruses” that may have “pandemic potential.” The document, from HHS Secretary Xavier Becerra, specifically mentions three types of Avian Influenza strains: H1N1 (from 2009); H7N9 (from the 2013 amendment);, and H5N1 (from the 24 March 2024 USDA statement regarding H5N1 infections in dairy cows in Kansas and in Texas.) https://public-inspection.federalregister.com/2024-16247.pdf. Below is a screenshot from the AHA (American Hospital Association) press release:

And, for reference, here is the Congressional Research Service Legal Sidebar document related to what the HHS Secretary can “declare” under the PREP Act (including removing liability options), updated 21 July 2023: https://crsreports.congress.gov/product/pdf/LSB/LSB10730, “The PREP Act and COVID-19, Part 2: The PREP Act Declaration for COVID-19 Countermeasures.”

This was followed by a tweet from Robert Kennedy, Jr.: https://twitter.com/RobertKennedyJr/status/1816905031653675473, a screenshot of which follows:

Meanwhile, the USDA had already issued a press release regarding how dairy farmers can apply to receive expanded livestock assistance to compensate for milk production lost due to their cows infected with H5N1: www.usda.gov/media/press-releases/2024/06/27/usda-begin-accepting-applications-expanded-emergency-livestock, “USDA to Begin Accepting Applications for Expanded Emergency Livestock Assistance Program to Help Dairy Producers Offset Milk Loss Due to H5N1”, dated 27 June 2024.

Which was followed, in turn, by a CDC release regarding the government’s response to the current H5N1 Avian Influenza situation: www,cdc,gov/bird-flu/spotlights/h5n1-response-07262024.html; a screenshot from the release is below:

So, it would appear that the HHS gave the “go-ahead” for a kind of “EUA” regarding the use of the protein-subunit H5N1 “vaccine”, AUDENZ (a supply is already in the National Vaccine Stockpile); and, for the increased production of this “vaccine.” What follows is a “closer look” at AUDENZ. Yours Truly will begin with the FDA-issued Fact Sheet for healthcare providers for this “vaccine”: www.fda.gov/media/135020/download; three screenshots from the document are below. The first screenshot shows clearly that there was no Placebo group (Control/saline group) in at least two clinical trials for AUDENZ. The second screenshot shows clearly that no Toxicology studies were performed for AUDENZ. The third screenshot is Page 10 of the Fact Sheet.

Note this language in the first screenshot: “In both Studies 1 and 2, all SAEs appeared unrelated to study treatment.” This indicates at least two important details: One, that Serious Adverse Events (SAEs) did occur during at least two clinical trials of AUDENZ; and, Two, that these Serious Adverse Events were not considered to be related to the clinical trials for AUDENZ. This is the same type of language that Pfizer-BioNTech used regarding Serious Adverse Events that occurred during the (shortened and data-compromised) clinical trials for the company’s “flagship” COVID-19 modRNA “vaccine” BNT162b2. Note also that a “complete dose series” for AUDENZ is two separate doses of 0.5mL each, for all age groups age six months and up. AUDENZ uses an adjuvant (an ingredient that facilities the activities of the injectable) called MF59. MF59 is a squalene-based, oil-in-water adjuvant. The Safety Data Sheet for MF59 is here: https://file.medchemexpress.com/batch_PDF/HY-153206/MF59-SDS-MedChemExpress.pdf. The product is listed as “Not a hazardous product or mixture” in section 2.2 of this document. However, reading further down the same document, one finds all sorts of contradictory information in the sections on “First Aid Measures”, on “Handling and Storage”, on “Exposure Controls”, and more.

Note also the list of reported adverse events in section 6.2 of Page 10, above. These are same types of adverse events reactions to the Pfizer-BioNTech modRNA COVID-19 “vaccine”, BNT162b2, in the post-authorization report that this company gave to the FDA on 30 April 2021; and in reports to VAERS; and, which are listed within the FDA-issued Fact Sheet for Healthcare Providers for the “2023-2024 Formula COVID-19 Vaccine” by Pfizer-BioNTech (www.phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf; www.openvaers.com/; www.fda.gov/media/167211/download?attachment. Very troubling are the listings in section 6.2 of Page 10 above in the AUDENZ fact sheet for “convulsions”; “demyelination”; “encephalitis”; and, “Guillain-Barre’ syndrome.”

A blog post by Dr. Jessica Rose, PhD, on 27 June 2024, presents a summary of clinical trial for AUDENZ (NCT02839440), in which she proves that the fatality rate is 1/200 chances for AUDENZ: https://jessicar.substack.com/p/1200-chance-of-death-in-context-of, “1/200 chance of death in context of new bird flu injection – 5 times higher than placebo according to clinical trial.” NCT02839440 did have a Placebo control group, (Scroll down the blog post to the discussion of this clinical trial for AUDENZ.)

To date, Yours Truly can find no exact set of CPT Codes for AUDENZ. The closest item found is here: www.hhs.gov/guidance/document/flu-shot-coding-0; the listing is “Q2039 Influenza virus vaccination otherwise specified.”

AUDENZ is produced by CSL Seqirus, part of the much-larger CSL multinational drug company. Following is a JPG of the list of CSL offices and locations, sourced from: www.csl.com/:

The United States government awarded CSL Seqirus a contract to produce millions of doses of an Avian Influenza “vaccine” in May 2024: www.cslseqirus.us/news/csl-seqirus-announces-us-government-award-in-response-to-avian-influenza. The “vaccine” will be manufactured by the CSL Seqirus facility at Holly Springs, North Carolina. This facility was built in partnership with BARDA (Biomedical Advanced Research and Development Authority), a department of the United States government. The Avian Influenza “vaccine” that this facility will manufacture is “cell-based”, as opposed to “egg-based”; with a six-month “turnaround” for production: www.csl.com/we-are-csl/our-business-and-products/csl-seqirus/csl-seqirus-manufacturing-technologies. Below are two images from the article related to this facility:

Note that whatever Avian Influenza cell-based “vaccine” from the CSL Seqirus facility at Holly Springs will use the MF59 adjuvant. (By the way, MF59 is trademarked by Novartis AG, which was acquired by CSL.)

So far, it appears that the H5N1 strain of Avian Influenza is the one that the United States government is focused upon. However, here’s where the trail veers to another path.

Please refer back to the American Hospital Association press release above in today’s post. Note this language: “The amendment now applies to pandemic influenza A viruses and others with pandemic potential, such as the current H5N1 strain of bird flu…” (Italics, Yours Truly) In Yours Truly’s opinion, this is “a hole big enough to drive a truck through” — or, perhaps, another strain of Avian Influenza.

The following article beings to “lift the curtain” on what ** may ** really be going on — which, again in Yours Truly’s opinion, appears to be a kind of “sleight-of-hand”: www.naturalnews.com/2024-07-26-fda-grant-eua-mrna-bird-flu-vaccines.html, “Pandemic 2.0 ready to go: FDA to grant emergency use authorization (EUA) to mRNA bird flu shots, just like what happened with COVID“, by Ethan Huff. And, “right out of the gate”, the article begins with this:

But, wasn’t the “upcoming potential bird flu pandemic” supposed to be the H5N1 strain that the government is warning about? Where does the H5N8 strain come in? According to Wikipedia, the H5N8 strain of Avian Influenza is “is typically not associated with humans.” https://en.wikipedia.org/wiki/Influenza_A_virus_subtype_H5N8. Very few humans have contracted a case of H5N8; this virus strain predominates among wild birds. However, the mortality rate among wild birds infected with H5N8 is “at least 75%”, again according to the Wikipedia article above.

Now, turning to the American Medical Association’s issuing new CPT Codes for the use of an H5N8 “vaccine.” One media outlet that Yours Truly found has this: https://revcycleintelligence.com/news/ama-updates-cpt-code-set-for-avian-influenza-vaccines, dated 22 July 2024. Below is a screenshot from the article, with the new CPT codes:

Note that the American Medical Association owns the rights for the CPT codes. This means that the AMA gets a “royalty payment” every time a CPT code is used. The AMA notice regarding the CPT codes for H5N8 is here: www.ama-assn.org/press-center/press-releases/ama-announces-cpt-update-avian-influenza-vaccines, dated 19 July 2024. Below is a screenshot from the notice:

What’s going on here? The picture is, to say the least, somewhat “murky.” There are, however, a few potential clues. Among them is this: www.pennmedicine.org/news/news-releases/2024/may/penn-researchers-develop-experimental-mrna-avian-flu-vaccine, dated 23 May 2024. Note on the screenshot, below, from the article, the language regarding “a specific type of the H5N1 virus”; and, that animals other than wild birds were being used for the experiments:

Here is another clue, from 5 June 2024: www.idsociety.org/science-speaks-blog/u.s.-orders-4.8-million-doses-of-a-cell-based-adjuvanted-h5-vaccine-for-avian-flu-preparedness#/+/0/publishedDate_na_dt/desc/, by Daniel R. Lucey, MD, PhH, FIDSA. Below is a screenshot from this article:

Note the language regarding “pre-pandemic vaccine that is well-matched to the H5 of the currently circulating H5N1 strain,…” (bolding, Yours Truly)

A third clue is here: https://twitter.com/RenzTom/status/1816110256843264368; a screenshot of part of his tweet is below:

And, a fourth clue is here: https://clinicaltrials.gov/ct2/show/NCT05874713, a clinical trial that appears to be in the “wrapping-up” stages regarding testing an mRNA-based H5N8 “vaccine.” Below is a screenshot from the Clinical Trials webpage for this clinical trial:

Note the very low test subject enrollment (480 persons); the presence of the MF59 adjuvant in the H5N8 “vaccine” candidate used in the clinical trial; and, a “two-dose” series of “primary run” injections of the “vaccine” candidate, followed by a “booster shot” on Day 209 for the H5N8 “vaccine” candidate.

There are three other clinical trials of an H5N8 “vaccine” listed on the https://clinicaltrials.gov/ website: NCT02624219 (Completed); NCT05975840 (Active); and, NCT03014310 (Completed.) All of these clinical trials were/are Phase I or Phase I/II. None of them have a Placebo/saline control group. Each of them have fewer than 600 subjects (NCT02624219 had 275 test subjects.) Two of these three other clinical trials have the NIAID as the Sponsor.

What does all this mean? Is it possible that the current H5N1 “Avian Influenza infecting cattle, cows, and domesticated pets, in addition to poultry” situation, while it is indeed occurring, is also a sort of “Look, squirrel!” to distract from something that may be more dangerous?: from, perhaps, Gain-of-Function experiments on the H5N8 strain of the Avian Influenza (recall that this strain has a 75%+ mortality rate among the wild birds that it infects); plus, perhaps. the development of “vaccines” for this “perhaps-enhanced” H5N8 strain, which may include the millions of doses of an “Avian Influenza cell-based vaccine” that will be manufactured at the CSL Seqirus facility in North Carolina? In other words, “Pandemic 2.0”?

Good Energy, Peace, Respect: PAVACA

The 2024-2025 Formula COVID-19 “Vaccines”: Injection Dose #10

The above is a vintage image of mass vaccination. (Courtesy Google Images.)

This series on the disaster of the COVID-19 virus itself, and of the COVID-19 “vaccines”, is dedicated to the memory of Yours Truly’s cousin Bill, who “died suddenly and unexpectedly” in September 2023.

The origination of today’s post begins here: www.dossier.today/p/double-digits-biden-admin-tells-americans, “Double Digits: Biden Admin tells Americans that it’s soon time for their 10th Covid shot“, by Jordan Schachtel, 13 June 2024. (Mr. Schachtel wrote about the ninth COVID-19 “vaccine” injection here: www.dossier.today/p/dose-number-nine-cdc-panel-green, “Dose number NINE: CDC panel green lights yet another Covid mRNA shot“, 29 February 2024. The CDC recommended that persons over age 65 take another “booster shot” of either the Pfizer-BioNTech or of the Moderna “2023-2024 Formula COVID-19 Vaccine” of these manufacturers.) A person age 65 or older, if that person adhered to every CDC recommendation regarding taking a COVID-19 “vaccine” injection since December 2020 (when the FDA granted first Emergency Use Authorization (EUA) to Pfizer-BioNTech and to Moderna for these companies’ “flagship” modRNA COVID-19 “vaccines” (BNT162b2 by Pfizer-BioNTech; and, mRNA-1273 by Moderna), would have taken injection number nine starting on 28 February 2024.

Today’s post is long. There is a large amount of information to “unpack.” Stay with me here.

Below is an image from the FDA’s 13 June “updated” authorization announcement for the “2024-2025 Formula COVID-19 Vaccine”, the TENTH injection dose of the modRNA “vaccine” formula: www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2024.

Note the language regarding the “selection of a specific JN.1 lineage SARS-CoV-2 strain…” More about that later.

The trail behind the 5 June 2024 FDA announcement begins with the VRBPAC Briefing Document for the meeting held on 28 June 2022: www.fda.gov/media/159452/download, “FDA Briefing Document Vaccines and Related Biological Products Advisory Committee Meeting June 28, 2022.” It was at this meeting that the FDA “codified” the types of “strain composition recommendations” that the agency would use regarding “new versions” of COVID-19 “vaccines.” Yours Truly presents page 17, page 18, and page 19 of this document:

It appears that the FDA simply decided that it would be permissible for the agency to authorize a new COVID-19 “vaccine” strain composition along what, in Yours Truly’s opinion, may be called “very flexible” options. For example, the Pfizer-BioNTech XBB.1.5 COVID-19 “vaccine”, which was FDA authorized in the fall of 2023, had test results only from mouse testing prior to FDA authorization. Following are: The link to the Pfizer-BioNTech slide presentation about this “vaccine” to the CDC’s ACIP committee (Advisory Committee on Immunization Practices) meeting of 12 September 2023; and, an image of slide CC4 from this presentation. First, the presentation: www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-09-12/10-COVID-Modjarrad-508.pdf.

Second, slide CC-4 from the above presentation:

The XBB.1.5. Pfizer-BioNTech COVID-19 “vaccine” had only been given as a single injection to humans in the company’s clinical trial; a clinical trial which had only just begun prior to the ACIP meeting. Slide CC-5 of the presentation, the start of the company’s human trial of this “vaccine”, is below:

Slide CC-6 of the presentation has to do with the mouse studies of this “vaccine”, which were of longer duration.

Notwithstanding the above, the FDA authorized the use of the company’s XBB.1.5 COVID-19 “vaccine” on 11 September 2023 (in Yours Truly’s opinion, it appears that the ACIP meeting of 12 September 2023 was a “catch-up” formality.) It also appears (again, in Yours Truly’s opinion), that the FDA used a very loose interpretation of “Option 4” on page 18 of the FDA Briefing Document above in granting the EUA for this “vaccine”.

** Now, on to the latest “new version” of the COVID-19 “vaccines”, the “2024-2025 Formula COVID-19 Vaccines”, that the FDA authorized in June 2024.

The following linked items are important regarding background information related to this situation and to the FDA: First, the FDA document, stating that the agency would “align” its COVID-19 “vaccine” antigen composition to the recommendations of the World Health Organization’s TAG-CO-VAC recommendations: www.fda.gov/media/179139/download (the TAG-CO-VAC recommendation for the “2024-2025 Formula COVID-19 Vaccines” was to use the JN.1 strain); second, the FDA document regarding “considerations and recommendations” for the “2024-2025 Formula COVID-19 Vaccine” composition: www.fda.gov/media/179145/download; third, the FDA announcement of the 5 June meeting of its VRBPAC committee (Vaccines and Related Biological Products Advisory Committee.): www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-june-5-2024-meeting-announcement. From this last link, chick on “Event Materials” to see the slide presentations and other items that were discussed at this meeting.

Two important items from the “Event Materials” list: the FDA Briefing Document; and the VRBPAC roster for this meeting. First, the FDA Briefing Document: www.fda.gov/media/179003/download; and, second, the VRBPAC roster for this meeting: www.fda.gov/media/179225/download. The roster for the 5 June 2024 meeting has some “familiar” members and speakers: Paul Offit, MD; and Peter Marks, MD (director of CBER [Center for Biologics Evaluation the Research of the FDA]); and, among the “Temporary Voting Members”, are: Bruce Gellin, M.D., M. PH., the Chief of Global Public Health Strategy for the Rockefeller Foundation; and, Melinda Wharton, M.D., M. PH., Associate Director of Vaccine Policy of the CDC. (Italics mine)

The VRBPAC members voted unanimously to endorse the Pfizer-BioNTech, the Moderna, and the Novavax “2024-2025 Formula COVID-19 Vaccine” by these companies, based on the presentations of these companies’ representatives at the meeting. Yours Truly can find no registered human clinical trials performed in advance of the 5 June VRBPAC meeting by Pfizer-BioNTech, or by Moderna, or by Novavax, for any “2024-2025 Formula COVID-19 Vaccine”; that would indicate that any “clinical trials” were performed in these companies’ facilities on mice; and that any “human trials” were also performed in these companies’ facilities, prior to the meeting. The FDA then issued the agency’s original announcement of 7 June 2024: www.fda.gov/news-events/press-announcements/fda-roundup-june-7-2024; and, a screenshot from this announcement:

Note in particular “…the selection of a specific JN.1 lineage SARS-CoV-2 strain (e.g., JN.1. or KP.2) and expressed a strong preference for JN.1.” Here’s where it starts to “get interesting.”

First, on 12 April 2024 (well ahead of the 5 June VRBPAC meeting), Pfizer-BioNTech issues a statement regarding the company’s “taking reservations” for the coming “2024-2025 Formula COVID-19 Vaccine” (also, see the Pfizer-BioNTech presentation at the 5 June meeting, linked above): www.cvdvaccine-us.com/reservation. This is followed, after the meeting, by Moderna filing an application with the FDA for a “vaccine” to target the JN.1. COVID-19 strain (also, see the Moderna presentation at the 5 June meeting, linked above): https://investors.modernatx.com/news/news-details/2024/Moderna-Files-FDA-Application-for-the-JN.1-Targeting-COVID-19-Vaccine/default.aspx; then, Novavax files with the FDA for that company’s version (also, see the Novavax presentation at the 5 June meeting, linked above): https://ir.novavax.com/press-releases/2024-06-14-Novavax-Submits-Application-to-U-S-FDA-for-Updated-Protein-based-2024-2025-Formula-COVID-19-Vaccine.

But then, “something happens”, and the FDA suddenly makes a large “about-face” and switches its “2024-2025 Formula COVID-19 Vaccine” choice to the KP.2 strain on 13 June 2024: www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2024. This is the “second” announcement, which was cited at the beginning of today’s post.

What was it that happened? Part of the answer lies in the fact that the NIH and Moderna co-own the patents (and, therefore, share the royalties) for the Moderna “flagship” modRNA COVID-19 “vaccine”, mRNA-1273. This agreement would extend to “descendant clone COVID-19 vaccines” by Moderna. www.citizen.org/article/modernas-mrna-1273-vaccine-patent-landscape/. The NIH’s Dale and Betty Bumpers Vaccine Research Center (part of NIAID — which Dr. Anthony Fauci led from November 1984 until his retirement in December 2022) and Moderna co-developed mRNA-1273. https://covid19.nih.gov/news-and-stories/nih-vaccine-research-center; a screenshot from the article is below:

The other part of the answer is that Moderna was already developing a KP.2 strain COVID-19 “vaccine” for 2024-2025. This, and the FDA’s decision to shift away from the JN.1 strain to the KP.2 strain, are described in this post at Sasha Latypova’s blog: https://sashalatypova.substack.com/p/all-roads-lead-to-resilience, “All Roads lead to Resilience. FDA is removing competitors for the Pentagon & CIA’s baby…Moderna”, 23 June 2024.

The FDA’s “about-face” announcement regarding the switch from the JN.1 strain to the KP.2 strain was also covered here: www.contagionlive.com/view/fda-advises-manufacturers-to-consider-kp-2-strain-for-covid-19-vaccines, 14 June 2024, by Sophia Abene. Below is a screenshot from this article:

However, there’s yet another detail in play here, regarding the FDA’s switch, “based on evaluation of the most recent circulating strains of COVID-19”, from JN.1 to KP.2 — the CIA and the Pentagon. Here is a screenshot from Sasha Latypova’s Substack article:

Here is the report, linked from the Latypova blog article cited above, that describes the CIA-linked company, “National Resilience”, or “Resilience”, that manufactures the RNA for the Moderna modRNA line of COVID-19 Omicron “vaccines”: https://unlimitedhangout.com/2022/08/investigative-reports/rna-for-modernas-omicron-booster-manufactured-by-cia-linked-company/, by Whitney Webb, 17 August 2022. Below is a screenshot image from this blog article:

And here is story on this “interesting development”, from Resilience: www.businesswire.com/news/home/20210908005443/en/Resilience-to-Manufacture-mRNA-for-Moderna’s-COVID-19-Vaccine, 8 September 2021. Note that per this “multi-year contract”, Resilience manufactures the mRNA for the Moderna COVID-19 “vaccines” at this Canadian facility. Resilience was founded in 2020.

But wait, there’s more! Resilience lists multiple “partners”, such as the Mayo Clinic. The company also, apparently, has a “partnership” with the United States Army’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense https://resilience.com/learn/partnerships. Below is a screenshot from this website:

The website link in the screenshot above is broken. Here is the Army’s website on this: wwwt2.army.mil/T2-Laboratories/Designated-Laboratories/Joint-Program-Executive-Office-for-Chemical-Biological-Radiological-and-Nuclear-Defense/. Note: this link may or may not work. One will need to do a search for “Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense” to see links to this department of the United States Army. One such link: https://globalbiodefense.com/directory/name/joint-program-executive-office-for-chemical-biological-defense-jpeo-cbd/.

It appears, then, in Yours Truly’s opinion, that the FDA was perhaps “reminded” of the”details” regarding the NIH-Moderna co-ownership (and royalties – sharing) agreement related to Moderna’s modRNA COVID-19 “vaccines”; and, the role of the CIA-Pentagon-National Resilience (aka Resilience) in manufacturing the mRNA used in the Moderna COVID-19 Omicron “booster vaccines” — and the KP.2. strain is indeed a “descendant strain” in the Omicron lineage (as is the JN.1 strain.) Hence, the FDA’s 2024-2025 COVID-19 “vaccine” strain “sudden switch” announcement of 13 June 2024, only one week after the agency gave the nod to the JN.1 strain.

In Yours Truly’s opinion, it is statistically, medically, and ethically impossible for a new vaccine (let alone any COVID-19 “vaccine”) to be developed; tested (on lab animals, then on human subjects); the test data thoroughly collated and analyzed for “safety and efficacy” on both lab animals and on human subjects; then, which data is presented to the CDC / FDA for consideration; then, these agencies doing their own “due diligence” research; then, and only then, being granted an EUA by the FDA; then, and only then, manufactured for use in humans — in a time span of fewer than three to five years, let alone within a time span of only a few months. It appears, again in Yours Truly’s opinion, that the CDC and the FDA are playing “fast and loose” with the health and safety of the people who choose (or will be “mandated”) to take the “2024-2025 Formula COVID-19 Vaccine.” And, also, that “other entities” are in play here to perhaps “influence” decision making by these agencies.

All of above is in addition to the fact that the COVID-19 “vaccines” (actually, gene therapy injections) have caused, are causing, and will cause, multiple health issues, serious adverse reactions, and deaths, in those who are “vaccinated.” Just two of the most recent discoveries: One, the COVID-19 “vaccines” can cause brain damage, an article by Dr. William Makis: www.globalresearch.ca/brain-damage-covid-19-mrna-vaccines/5861012, “Brain Damage Caused by COVID-19 mRNA Vaccines”, 26 June 2024. Below is a screenshot from Dr. Makis’ article:

The second most recent discovery, that the COVID-19 “vaccines” reduce life expectancy (even in “all-cause” analysis) among COVID-19 “vaccinated” persons, by Dr. Peter A. McCullough: https://petermcculloughmd.substack.com/p/breaking-publication-a-critical-analysis, “BREAKING Publication — A Critical Analysis of All-Cause Deaths during COVID-19 Vaccination in an Italian Province”, 1 July 2024. The peer-reviewed paper is here: https://doi.org/10.3390/microorganisms12071343, “A Critical Analysis of All-Cause Deaths during COVID-19 Vaccination in an Italian Province”, Marco Alessandria, et al., published 30 June 2024. Below is a screenshot from the Conclusions section of this paper:

In Yours Truly’ opinion, it is apparent at “half a glance” that the COVID-19 “vaccines” (actually, gene therapy injections) must be completely withdrawn for human use until these products have been fully investigated, and then re-designed, before being re-introduced for human use; and, that there is no “co-ownership” or sharing of royalties between a government agency and a COVID-19 “vaccine” manufacturer; and, that there is no involvement of the United States military in the development or manufacture of such products.

Peace, Good Energy, Respect: PAVACA


PAVACA’s Top 12 List of Damages the COVID-19 “Vaccines” Can Do to the “Vaccine” Recipient

The above is an image of Father Christmas from a vintage postcard.

The following may be a bit “heavy” — please regard it as a kind of rich “Christmas Pudding” of COVID-19 “vaccine” knowledge base. Not a “lump of coal!”

Just in time for Christmas, Yours Truly presents a list of what she considers to be the “Top 12” types of damage that the COVID-19 “vaccines” can do to the body of the “vaccine” recipient. This list has been gathered from the 1600+ hours of investigating “all things COVID-19” that Yours Truly has done since March 2020. Therefore, it is only her opinion. People who read through the report that Pfizer-BioNTech gave to the FDA on 30 April 2021, regarding the over 1,000 serious adverse events medical conditions that the company’s COVID-19 “vaccine”, BNT162b2, caused in persons who took this “vaccine” IN FEWER THAN THREE MONTHS after the FDA granted the initial EUA for this “vaccine” in December 2020 for its use in the United States, may come up with “Top Lists” of their own. The report can be found here: https://phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf, BNT162b2 5.3.6 Cumulative Analysis of Post-authorization Adverse Events Reports. The APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST, found at the end of the report, lists these serious adverse events conditions reports that BNT162b2 caused in “vaccinated” persons.

However, what is NOT opinion is that the FDA then knew, on 30 April 2021, that the Pfizer-BioNTech “flagship” COVID-19 “vaccine” BNT162b2 (actually, an untried gene therapy injection), was capable of damaging the body of the “vaccine” recipient in over 1,000 different ways, including the ways on Yours Truly’s “Top 12 List..” However, instead of performing its regulatory (and moral and ethical) obligations to immediately pull BNT162b2 off the market and out of use until the situation could be further investigated, the FDA chose to CONTINUE the EUA that it granted in December 2020 for BNT162b2. Not only that, but the FDA went ahead and granted “full approval” for the use of the European version of BNT162b2, called COMIRNATY, in the United States. Not only that, but the FDA granted EUA’s for the Pfizer-BioNTech COVID-19 “bivalent vaccine” to be used in the United States. Finally, in the spring of 2023, the FDA quietly stopped all use of BNT162b2 in the United States — in Yours Truly’s opinion, after mounting reports of serious adverse events, including deaths, being caused by this “vaccine” were beginning to circulate widely and to be confirmed by professional researchers and by doctors — and substituted the use of the Pfizer-BioNTech (and the Moderna) “booster vaccines” for the Omicron variant. In the summer of 2023, the FDA granted EUA’s for both the Pfizer-BioNTech and for the Moderna “2023-2024 Formula COVID-19 Vaccine”, which had only been tested on mice.

Here is Yours Truly’s “Top 12 List”: The first nine, from the APPENDIX 1. cited above:

Death: neonatal and Sudden unexplained death in epilepsy (page 3 and page 8); Myocarditis and Pericarditis (page 6 and page 7); Stroke (Cerebral artery embolism page 2; Cerebral thrombosis, page 2); Thrombotic Stroke (page 9), among other types; THIRTY different types of Autoimmune disorders (page 2); FORTY different types of Herpes disorders (page 4 and page 5); THIRTY-PLUS different types of Liver disorders (page 4); TWENTY-FIVE different types of Immune System disorders (page 5); SIXTEEN different types of Neurological (brain and/or central nervous system) disorders (page 6); and, COVID-19 and COVID-19 Pneumonia (page 3).

As an example, here is a handy-dandy image of page 4 of the APPENDIX 1., with Yours Truly’s notes:

To round out the “Top 12 List” of COVID-19 “vaccine” damage to the body of the recipient, there are these three:

One: Heart tissue and lung tissue damage / destruction: Please refer to: https://doctors4covidethics.org/wp-content/uploads/2022/08/causality-article.pdf, by Michael Palmer, MD, and Sucharit Bhakdi, MD; Two: Fetal / Neonatal disorders, including 1p36 deletion syndrome (also listed on page 1 of the APPENDIX 1.): Please refer to the following regarding 1p36 deletion syndrome: https://medlineplus.gov/genetics/condition/1p36-deletion-syndrome/ (more on this condition below); and, Three: Cancer induced with the assistance of the SV40 cancer promoter DNA that has been recently discovered in the Pfizer-BioNTech COVID-19 “vaccines” (more on this below): Please refer to the following: https://osf.io/preprints/osf/mjc97, “DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events”, David Speicher, Jessica Rose, Kevin McKernan, et al. From lines 94-95 of this paper: “McKernan, et al., found SV40 promoter-enhancer-ori [DNA], and SV40 polyA signal sequences in the Pfizer vaccines.” The SV40 promoter-enhancer DNA is also in the Pfizer-BioNTech COVID-19 “vaccines” that were used in the United States: https://rumble.com/v3r1pqf-vaccine-adulteration-wkevin-mckernan-byram-bridle-chris-martenson-steve-kir.html, beginning at 3:32 in the video. Please also refer to the letter of December 2023 from Florida Surgeon General, Dr. Joseph Ladapo, to the directors of the FDA and the CDC: www.floridahealth.gov/about/_documents/12-06-2023-DOH-Letter-to-FDA-RFI-on-COVID-19-Vaccines.pdf. Yours Truly will posit that, since the modRNA + its spike protein and the “Process 2” manufacturing method for the current “2023-2024 Formula COVID-19 Vaccine” by this company in use in the United States are both based on its original “vaccine” formulations (BNT162b2 and the “booster and bivalent vaccines”), it appears that this opens up the possibility that the SV40 promoter-enhancer DNA is present in this “vaccine” also. Important: The SV40 promoter-enhancer DNA in the Pfizer-BioNTech COVID-19 “vaccines” is not the entire code, only a part of it. In and of itself, this “partial code” likely would not cause cancer; however, it can be involved in the general damage / destruction that the COVID-19 “vaccines” do to the “vaccine” recipient’s body, which can, in turn, be involved in the onset of cancer, or the re-emergence of cancer already in remission, in that person’s body. In addition, Pfizer-BioNTech DID NOT TELL the Canadian health authorities, nor, apparently, the FDA in the United States, about the SV40 issue.

About the 1p36 deletion syndrome caused by the modRNA COVID-19 “vaccines”: This is particularly troubling, since it effects UNBORN children and THE SPERM AND THE EGGS OF THE “VACCINATED” PARENTS. 1p36 deletion syndrome is a multi-faceted condition that negatively affects fetal development. Infants born with this condition have severe intellectual difficulties; weak muscle tone; have vision, hearing, and heart issues; and either do not speak, or can only speak a limited vocabulary; among other things. Please refer to the MedlinePlus link, above, for further information. It has been proven that large amounts of the dangerous lipid nanoparticles AND the enhanced spike protein + its modRNA in the Pfizer-BioNTech COVID-19 “vaccine” migrate to, and lodge in, two important areas of the recipient’s body — the OVARIES and the TESTES. Please refer to the image below, directly from Pfizer-BioNTech, on page 8 of a document that the company gave to the FDA on 21 January 2021. The document is called BNT162b2 2.6.5 Pharmacokinetics Tabulated Summary. It is available through https://phmpt.org/.

Please also refer to this graphic, which shows what the modRNA COVID-19 “vaccines” do in the pregnant mother’s body and in the body her unborn child or her nursling child (this is from a CDC presentation):

1p36 deletion syndrome is “...caused by a deletion of genetic material from a specific region in the short (p) arm of chromosome 1…Most cases of 1p36 deletion syndrome are not inherited.” (per the MedlinePlus link, above.) Think about that.

Three “Christmas Bonuses” to to along with the “Top 12 List”: One: The COVID-19 “vaccines” can, and do, cause onset of psychosis in “vaccinated” persons. Please refer to the following: https://doi.org/10.24869/psyd.2022.377, “First Episode of Psychosis Following the COVID-19 Vaccination — A Case Series”, Tonka Borovina, et al.; Two: The risk of mortality increases for the “vaccinated” person for each injection they take of a COVID-19 “vaccine.” Please refer to the following: www.theburningplatform.com/2023/12/10/newly-leaked-data-shows-just-how-dangerous-the-covid-vaccines-are/; and, Three: The damage / destruction of the “vaccine” recipient’s immune system and connections to what is called “turbo-cancers” that this induces. Please refer to the following: https://jessicar.substack.com/p/igg4-and-cancer-a-mechanism-of-action; and, to https://vigilantnews.com/post/turbo-cancer-death-from-turbo-cancers-were-in-trouble-says-dr-ryan-cole/.

A final note on the current “2023-2024 Formula COVID-19 Vaccines” by both Pfizer-BioNTech and by Moderna: These apparently do include the ingredients (although in smaller amounts) of the original modRNA COVID-19 “vaccines” made by each company (BNT162b2 by Pfizer-BioNTech; and, mRNA-1273 by Moderna), with additional elements of the Omicron XBB 1.5 variant lineage. Please refer to the following: www.fda.gov/media/167211/download, page 39 (Pfizer-BioNTech); www.fda.gov/media/167208/download, page 34 (Moderna); and, https://covid19.nih.gov/covid-19-vaccines.

As an aside, in case readers hear someone “congratulating themselves” for their taking either the Novavax or the Johnson & Johnson (Janssen) COVID-19 “vaccines”, because they believed that somehow these “vaccines” are “safer” than those of Pfizer-BioNTech or of Moderna: The Novavax COVID-19 “vaccine” uses the same modRNA + its spike protein as in the Pfizer-BioNTech and the Moderna COVID-19 “vaccines.” The difference with the Novavax COVID-19 “vaccine” is that the SARS-CoV-2 virus is “marinated” in an insect culture, with the resulting modRNA “harvested” and mixed with “adjuvants” made from soap tree bark; this “vaccine” also uses lipid nanoparticles (LNPs.). The Johnson & Johnson (Janssen) COVID-19 “vaccine” was removed from use (revoked) in the United States by the FDA in May 2023. However, persons who took this “vaccine” prior to May 2023, are at risk for Thrombosis and Thrombocytopenia, as listed on the “black letter warning” area on the (revoked) FDA Fact Sheet for Healthcare Providers for this “vaccine.” Please refer to the following: for the Novavax COVID-19 “vaccine”: www.fda.gov/media/159897/download, page 33; www.hackensackmeridianhealth.org/en/healthu/2022/08/09/novavax-vaccine-how-its-different-and-how-it-works; and, for the Johnson & Johnson (Janssen) revoked COVID-19 “vaccine”: www.fda.gov/media/146304/download, page 1.

Yours Truly will make it clear she believes that COVID-19, in its variants forms, is still a threat to health. Since one is a concerned citizen, not a healthcare practitioner, one can only offer the following thoughts:

First: it is of primary importance that all people have, and maintain, the best level of personal health and immunity that is possible; “un-vaccinated” people have a primary responsibility here to themselves. Second: It is of primary importance that all “un-vaccinated” people follow a protocol for prophylaxis against COVID-19, such as those outlined at https://covid19criticalcare.com/, and including judicious exposure to sunlight and daily mild to moderate exercise. Third: It is of primary importance that all people follow “common sense” approaches, such as washing the hands, and staying away from sick people if possible. Fourth: It is of importance that “vaccinated” people know about various protocols to try and mitigate the dangerous effects of the COVID-19 “vaccines” at work in their bodies; https://covid19criticalcare.com/treatment-protocols/. Fifth: It is of great importance to have and keep a positive connection with a Supreme Being.

“Then will you know the truth, and the truth shall set you free.” John 8:32

It is past time, in Yours Truly’s opinion, to bring to justice those who were/are involved in the development and manufacture of the COVID-19 “vaccines”; and those in the FDA / CDC / AMA, and other medical agencies and organizations, who either know, should have known, or knew of, the dangers of these “vaccines” — but still continue to push them. Some examples: Albert Bourla, DVM (CEO of Pfizer Inc.); Stephane Bancel (CEO of Moderna); Alex Gorsky (CEO of Johnson & Johnson until 2022); Anthony Fauci, MD (former head of the NIAID); Francis Collins, MD (former head of the NIH); Janet Woodcock, MD (former Acting Commissioner of the FDA); Rochelle Walensky, MD (former Director of the CDC); Peter Daszak, CEO of EcoHealth Alliance; Robert Califf, MD (current Commissioner of the FDA); Mandy Cohen, MD (current Director of the CDC); Jesse M. Ehrenfeld, MD, (current head of the AMA); and, Ralph Baric, PhD, of the Baric Lab at the University of North Carolina, Chapel Hill.

A link to a another of Yours Truly’s pieces on COVID-19 and the COVID-19 “vaccines”, that has a compilation: www.theqtree.com/2023/11/29/the-covid-19-vaccines-pave-the-way-for-turbo-cancers-and-a-note-on-the-virus-itself/

Best wishes for a good Christmas 2023 and New Year 2024. Peace, Good Energy, Respect: PAVACA